PRKD3
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A4FU28 | S140 | Sugiyama | CTAGE9 | AAAEEARSLEATCEKLSRsNsELEDEILCLEKDLKEEKSKH |
| A5A3E0 | S1065 | Sugiyama | POTEF A26C1B | ILASLSTFQQMWISKQEyDEsGPsIVHRKCL__________ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00116 | S632 | Sugiyama | AGPS AAG5 | SLSHHHGVGKLRKQWLKESIsDVGFGMLKSVKEyVDPNNIF |
| O00299 | S211 | Sugiyama | CLIC1 G6 NCC27 | CKKYRGFTIPEAFRGVHRYLsNAyAREEFAstCPDDEEIEL |
| O00488 | S40 | Sugiyama | ZNF593 ZT86 | KAKRRRPDLDEIHRELRPQGsARPQPDPNAEFDPDLPGGGL |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O14646 | S1017 | Sugiyama | CHD1 | KRAETHENEPGPLtVGDELLsQFKVANFsNMDEDDIELEPE |
| O14646 | T1010 | Sugiyama | CHD1 | MDIDEILKRAETHENEPGPLtVGDELLsQFKVANFsNMDED |
| O14745 | S291 | Sugiyama | NHERF1 NHERF SLC9A3R1 | EALAEAALEsPRPALVRsAssDtsEELNsQDsPPKQDSTAP |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | S995 | Sugiyama | PPP1R12A MBS MYPT1 | ADRSLLEMEKRERRALERRIsEMEEELKMLPDLKADNQRLK |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15143 | S310 | Sugiyama | ARPC1B ARC41 | QSSQRGLTARERFQNLDKKAssEGGtAAGAGLDsLHKNsVs |
| O15355 | S527 | Sugiyama | PPM1G PPM1C | PRNTAELQPEsGKRKLEEVLstEGAEENGNsDKKKKAKRD_ |
| O15460 | T532 | Sugiyama | P4HA2 UNQ290/PRO330 | WVSNKWFHERGQEFLRPCGstEVD_________________ |
| O43175 | S14 | Sugiyama | PHGDH PGDH3 | _______MAFANLRKVLIsDsLDPCCRKILQDGGLQVVEKQ |
| O43175 | S251 | Sugiyama | PHGDH PGDH3 | VVNCARGGIVDEGALLRALQsGQCAGAALDVFTEEPPRDRA |
| O43324 | S100 | Sugiyama | EEF1E1 AIMP3 P18 | TQVDGHSSKNDIHTLLKDLNsyLEDKVYLTGYNFTLADILL |
| O43390 | S426 | Sugiyama | HNRNPR HNRPR | IVLAKPPDKKRKERQAARQAsRstAyEDyyyHPPPRMPPPI |
| O43390 | T429 | Sugiyama | HNRNPR HNRPR | AKPPDKKRKERQAARQAsRstAyEDyyyHPPPRMPPPIRGR |
| O43615 | S180 | Sugiyama | TIMM44 MIMT44 TIM44 | AESVSKGGEKLGRTAAFRALsQGVEsVKKEIDDsVLGQtGP |
| O43815 | S229 | Sugiyama | STRN | TEAEVKETAMIAKSELtDsAsVLDNFKFLEsAAADFsDEDE |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S69 | Sugiyama | CALU | HDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKDGFVt |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O60271 | S183 | Sugiyama | SPAG9 HSS KIAA0516 MAPK8IP4 SYD1 HLC6 | HTEMIHNYMEHLERTKLHQLsGsDQLEstAHsRIRKERPIs |
| O60343 | S485 | Sugiyama | TBC1D4 AS160 KIAA0603 | CERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPV |
| O60610 | S542 | Sugiyama | DIAPH1 DIAP1 | ALHSEKQQIATEKQDLEAEVsQLtGEVAKLTKELEDAKKEM |
| O60664 | S148 | Sugiyama | PLIN3 M6PRBP1 TIP47 | KVsGAQEMVssAKDTVAtQLsEAVDATRGAVQSGVDKTKsV |
| O60664 | S175 | Sugiyama | PLIN3 M6PRBP1 TIP47 | RGAVQSGVDKTKsVVtGGVQsVMGsRLGQMVLsGVDtVLGK |
| O60749 | S226 | Sugiyama | SNX2 TRG9 | PPAPEKSIVGMTKVKVGKEDssSTEFVEKRRAALERYLQRT |
| O60749 | S227 | Sugiyama | SNX2 TRG9 | PAPEKSIVGMTKVKVGKEDssSTEFVEKRRAALERYLQRTV |
| O60749 | S365 | Sugiyama | SNX2 TRG9 | AKSAAMLGNsEDHTALSRALsQLAEVEEKIDQLHQEQAFAD |
| O75340 | S120 | Sugiyama | PDCD6 ALG2 | RTYDRDNsGMIDKNELKQALsGFGYRLSDQFHDILIRKFDR |
| O75348 | S65 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | EQyRLQREKEFKAKEAAALGsRGsCstEVEKETQEKMTILQ |
| O75348 | S68 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | RLQREKEFKAKEAAALGsRGsCstEVEKETQEKMTILQtyF |
| O75369 | S2532 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ASKVTSKGAGLSKAFVGQKssFLVDCSKAGSNMLLIGVHGP |
| O75534 | S584 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | YSLSKGKGNKVSAEKVNKtHsVNGItEEADPTIysGKVIRP |
| O75937 | S81 | Sugiyama | DNAJC8 SPF31 HSPC315 HSPC331 | VLQIDPEVTDEEIKKRFRQLsILVHPDKNQDDADRAQKAFE |
| O76003 | S120 | Sugiyama | GLRX3 PICOT TXNL2 HUSSY-22 | LDGAHAPELTKKVQRHAssGsFLPSANEHLKEDLNLRLKKL |
| O76021 | S314 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | RNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPE |
| O94776 | Y437 | Sugiyama | MTA2 MTA1L1 PID | tTEPHSRGHLsRPEAQsLsPyttsANRAKLLAKNRQtFLLQ |
| O94804 | S875 | Sugiyama | STK10 LOK | RLQQQQKHENQMRDMLAQCEsNMSELQQLQNEKCHLLVEHE |
| O94806 | S27 | Sugiyama | PRKD3 EPK2 PRKCN | PPSAQKSVLPtAIPAVLPAAsPCssPKTGLsARLsNGsFSA |
| O94806 | S364 | Sugiyama | PRKD3 EPK2 PRKCN | IDNNDINSDSSRGLDDtEEPsPPEDKMFFLDPsDLDVERDE |
| O94806 | S376 | Sugiyama | PRKD3 EPK2 PRKCN | GLDDtEEPsPPEDKMFFLDPsDLDVERDEEAVKtIsPstsN |
| O94806 | S391 | Sugiyama | PRKD3 EPK2 PRKCN | FFLDPsDLDVERDEEAVKtIsPstsNNIPLMRVVQSIKHTK |
| O94806 | S393 | Sugiyama | PRKD3 EPK2 PRKCN | LDPsDLDVERDEEAVKtIsPstsNNIPLMRVVQSIKHTKRK |
| O94806 | S395 | Sugiyama | PRKD3 EPK2 PRKCN | PsDLDVERDEEAVKtIsPstsNNIPLMRVVQSIKHTKRKSS |
| O94806 | S41 | Sugiyama | PRKD3 EPK2 PRKCN | AVLPAAsPCssPKTGLsARLsNGsFSAPsLTNSRGSVHTVS |
| O94806 | S44 | Sugiyama | PRKD3 EPK2 PRKCN | PAAsPCssPKTGLsARLsNGsFSAPsLTNSRGSVHTVSFLL |
| O94806 | S452 | Sugiyama | PRKD3 EPK2 PRKCN | LRKRHYWRLDsKCLTLFQNEsGSKYYKEIPLSEILRISSPR |
| O94806 | S49 | Sugiyama | PRKD3 EPK2 PRKCN | CssPKTGLsARLsNGsFSAPsLTNSRGSVHTVSFLLQIGLT |
| O94806 | S539 | Sugiyama | PRKD3 EPK2 PRKCN | VAQSWEKAIRQALMPVtPQAsVCtsPGQGKDHKDLSTSISV |
| O94806 | S543 | Sugiyama | PRKD3 EPK2 PRKCN | WEKAIRQALMPVtPQAsVCtsPGQGKDHKDLSTSISVSNCQ |
| O94806 | S735 | EPSD|Sugiyama | PRKD3 EPK2 PRKCN | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRSKGYNR |
| O94806 | T17 | Sugiyama | PRKD3 EPK2 PRKCN | ____MSANNsPPSAQKSVLPtAIPAVLPAAsPCssPKTGLs |
| O94806 | T360 | Sugiyama | PRKD3 EPK2 PRKCN | IPMDIDNNDINSDSSRGLDDtEEPsPPEDKMFFLDPsDLDV |
| O94806 | T535 | Sugiyama | PRKD3 EPK2 PRKCN | VGLDVAQSWEKAIRQALMPVtPQAsVCtsPGQGKDHKDLST |
| O94806 | T542 | Sugiyama | PRKD3 EPK2 PRKCN | SWEKAIRQALMPVtPQAsVCtsPGQGKDHKDLSTSISVSNC |
| O94806 | T739 | Sugiyama | PRKD3 EPK2 PRKCN | CDFGFARIIGEKsFRRsVVGtPAyLAPEVLRSKGYNRSLDM |
| O94806 | Y742 | Sugiyama | PRKD3 EPK2 PRKCN | GFARIIGEKsFRRsVVGtPAyLAPEVLRSKGYNRSLDMWSV |
| O95071 | S115 | Sugiyama | UBR5 EDD EDD1 HYD KIAA0896 | NSGAGRTSRPGRTSDsPWFLsGSEtLGRLAGNTLGSRWSsG |
| O95602 | S240 | Sugiyama | POLR1A | NSKLTITFPAMVHRTAGQKDsEPLGIEEAQIGKRGYLTPTS |
| O96013 | S474 | SIGNOR | PAK4 KIAA1142 | VKLSDFGFCAQVSKEVPRRKsLVGtPYWMAPELISRLPYGP |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00558 | S415 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGGAsLELLEGKVLPGVDALsNI__________________ |
| P04075 | S176 | Sugiyama | ALDOA ALDA | EHtPsALAIMENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04792 | S15 | Sugiyama | HSPB1 HSP27 HSP28 | ______MTERRVPFsLLRGPsWDPFRDWyPHsRLFDQAFGL |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05023 | S519 | Sugiyama | ATP1A1 | sEPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQ |
| P05023 | S520 | Sugiyama | ATP1A1 | EPQHLLVMKGAPERILDRCssILLHGKEQPLDEELKDAFQN |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05997 | S1277 | Sugiyama | COL5A2 | APDDKNKTDPGVHATLKSLSsQIETMRSPDGSKKHPARTCD |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07339 | S37 | Sugiyama | CTSD CPSD | PASALVRIPLHKFTSIRRtMsEVGGsVEDLIAKGPVSKYSQ |
| P07711 | S329 | Sugiyama | CTSL CTSL1 | GGyVKMAKDRRNHCGIAsAAsyPtV________________ |
| P07814 | S335 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | PIEKNLQMWEEMKKGsQFGQsCCLRAKIDMSSNNGCMRDPt |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P08238 | S206 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEDQtEyLEERRVKEVVKKHsQFIGyPItLyLEKEREKEIs |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08758 | T10 | Sugiyama | ANXA5 ANX5 ENX2 PP4 | ___________MAQVLRGtVtDFPGFDERADAEtLRKAMKG |
| P09001 | Y265 | Sugiyama | MRPL3 MRL3 RPML3 | TGDIGRVWPGTKMPGKMGNIyRTEYGLKVWRINTKHNIIYV |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09972 | S176 | Sugiyama | ALDOC ALDC | ERTPSALAILENANVLARyAsICQQNGIVPIVEPEILPDGD |
| P0CG38 | S1065 | Sugiyama | POTEI | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG39 | S1028 | Sugiyama | POTEJ | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P0CG41 | S140 | Sugiyama | CTAGE8 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| P10412 | S89 | Sugiyama | H1-4 H1F4 HIST1H1E | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P11142 | S541 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EAEKYKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGK |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11388 | S1374 | Sugiyama | TOP2A TOP2 | sPPKtKTsPKLsNKELKPQKsVVsDLEADDVKGsVPLsssP |
| P11532 | S3623 | Sugiyama | DMD | EAKVNGttVssPstsLQRsDssQPMLLRVVGSQTSDSMGEE |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S593 | Sugiyama | EEF2 EF2 | SDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKARPFPDGL |
| P13674 | S366 | Sugiyama | P4HA1 P4HA | DAEIEIVKDLAKPRLRRAtIsNPITGDLETVHYRISKsAWL |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14618 | S97 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | sHGtHEyHAEtIKNVRtAtEsFAsDPILyRPVAVALDTKGP |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S514 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | LGVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEK |
| P14625 | S515 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVIEDHsNRtRLAKLLRFQssHHPtDItsLDQyVERMKEKQ |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15374 | S128 | Sugiyama | UCHL3 | KDKMHFESGSTLKKFLEEsVsMsPEERARyLENyDAIRVtH |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P15880 | T278 | Sugiyama | RPS2 RPS4 | EtVFtKsPyQEFtDHLVKtHtRVsVQRtQAPAVATt_____ |
| P15880 | T285 | Sugiyama | RPS2 RPS4 | PyQEFtDHLVKtHtRVsVQRtQAPAVATt____________ |
| P15924 | S1658 | Sugiyama | DSP | DVLDGHLREKQRTQEELRRLssEVEALRRQLLQEQESVKQA |
| P16401 | S92 | Sugiyama | H1-5 H1F5 HIST1H1B | GGYDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | S90 | Sugiyama | H1-3 H1F3 HIST1H1D | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | S89 | Sugiyama | H1-2 H1F2 HIST1H1C | AGyDVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNK |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19174 | S1233 | Sugiyama | PLCG1 PLC1 | PAKENGDLsPFsGtsLRERGsDASGQLFHGRAREGsFEsRy |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S580 | Sugiyama | NCL | PRGsPNARSQPSKTLFVKGLsEDttEEtLKEsFDGsVRARI |
| P22059 | S240 | Sugiyama | OSBP OSBP1 | DLSTCNDLIAKHGTALQRsLsELEsLKLPAESNEKIKQVNE |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22626 | S102 | Sugiyama | HNRNPA2B1 HNRPA2B1 | RPHsIDGRVVEPKRAVAREEsGKPGAHVtVKKLFVGGIKED |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P23528 | S41 | Sugiyama | CFL1 CFL | RKsstPEEVKKRKKAVLFCLsEDKKNIILEEGKEILVGDVG |
| P23921 | S780 | Sugiyama | RRM1 RR1 | KEKVSKEEEEKERNtAAMVCsLENRDECLMCGS________ |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P26038 | S527 | Sugiyama | MSN | ERTTEAEKNERVQKHLKALtsELANARDEsKKTANDMIHAE |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | S97 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | sLEELRVAGIHKKVARTIGIsVDPRRRNKstEsLQANVQRL |
| P26641 | S25 | Sugiyama | EEF1G EF1G PRO1608 | TLyTyPENWRAFKALIAAQYsGAQVRVLsAPPHFHFGQtNR |
| P27348 | S63 | Sugiyama | YWHAQ | LLsVAyKNVVGGRRSAWRVIsSIEQKTDTSDKKLQLIKDYR |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29692 | S64 | Sugiyama | EEF1D EF1D | sVILRDIARARENIQKsLAGssGPGAssGtsGDHGELVVRI |
| P29692 | S70 | Sugiyama | EEF1D EF1D | IARARENIQKsLAGssGPGAssGtsGDHGELVVRIAsLEVE |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30533 | S135 | Sugiyama | LRPAP1 A2MRAP | LNVILAKYGLDGKKDARQVtsNsLsGtQEDGLDDPRLEKLW |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P30622 | S1204 | Sugiyama | CLIP1 CYLN1 RSN | EELGRSRDEVTSHQKLEEERsVLNNQLLEMKKRESKFIKDA |
| P31943 | S269 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQsttGH |
| P31946 | S65 | Sugiyama | YWHAB | LLsVAyKNVVGARRSsWRVIsSIEQKTERNEKKQQMGKEYR |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P33527 | S915 | Sugiyama | ABCC1 MRP MRP1 | QMENGMLVTDsAGKQLQRQLsssssysGDISRHHNstAELQ |
| P35241 | S532 | Sugiyama | RDX | EERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHA |
| P35241 | S533 | Sugiyama | RDX | ERVTETQKNERVKKQLQALssELAQARDETKKTQNDVLHAE |
| P35613 | S277 | Sugiyama | BSG UNQ6505/PRO21383 | KITDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPG |
| P35613 | S279 | Sugiyama | BSG UNQ6505/PRO21383 | TDSEDKALMNGSESRFFVsssQGRSELHIENLNMEADPGQy |
| P36578 | S63 | Sugiyama | RPL4 RPL1 | NLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGGG |
| P36915 | S68 | Sugiyama | GNL1 HSR1 | tDtsDGEsVTHHIRRLNQQPsQGLGPRGYDPNRYRLHFERD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40337 | S68 | Sugiyama | VHL | LGAEEEMEAGRPRPVLRSVNsREPsQVIFCNRsPRVVLPVW |
| P40818 | T723 | Sugiyama | USP8 KIAA0055 UBPY | PAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPTVNRE |
| P41236 | T22 | Sugiyama | PPP1R2 IPP2 | AASTAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSK |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | S472 | Sugiyama | NAMPT PBEF PBEF1 | EYGQDLLHTVFKNGKVTKsysFDEIRKNAQLNIELEAAHH_ |
| P46060 | S24 | Sugiyama | RANGAP1 KIAA1835 SD | EDIAKLAETLAKTQVAGGQLsFKGKSLKLNTAEDAKDVIKE |
| P46060 | S454 | Sugiyama | RANGAP1 KIAA1835 SD | VstFLAFPsPEKLLRLGPKssVLIAQQTDTSDPEKVVSAFL |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S172 | Sugiyama | RPL5 MSTP030 | RTTTGNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNA |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P46779 | S91 | Sugiyama | RPL28 | RKPAtsyVRttINKNARAtLsSIRHMIRKNKYRPDLRMAAI |
| P46782 | S75 | Sugiyama | RPS5 | RYAAKRFRKAQCPIVERLtNsMMMHGRNNGKKLMTVRIVKH |
| P46940 | S343 | Sugiyama | IQGAP1 KIAA0051 | ALFRALQsPALGLRGLQQQNsDWYLKQLLSDKQQKRQsGQT |
| P47712 | S178 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | RQQRKEHIRESMKKLLGPKNsEGLHSARDVPVVAILGSGGG |
| P49588 | S775 | Sugiyama | AARS1 AARS | VTGAEAQKALRKAESLKKCLsVMEAKVKAQTAPNKDVQREI |
| P49840 | S21 | iPTMNet | GSK3A | MsGGGPsGGGPGGsGRARtssFAEPGGGGGGGGGGPGGsAs |
| P51532 | S1380 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEI |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51991 | S116 | Sugiyama | HNRNPA3 HNRPA3 | RPHKVDGRVVEPKRAVsREDsVKPGAHLtVKKIFVGGIKED |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52907 | S106 | Sugiyama | CAPZA1 | RFLDPRNKISFKFDHLRKEAsDPQPEEADGGLKsWREsCDs |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P53396 | S478 | Sugiyama | ACLY | EsRADEVAPAKKAKPAMPQDsVPsPRSLQGKSTTLFSRHTK |
| P53621 | S266 | Sugiyama | COPA | RGHyNNVSCAVFHPRQELILsNsEDKSIRVWDMSKRTGVQT |
| P53621 | S268 | Sugiyama | COPA | HyNNVSCAVFHPRQELILsNsEDKSIRVWDMSKRTGVQTFR |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S12 | Sugiyama | SUB1 PC4 RPO2TC1 | _________MPKSKELVsssssGsDsDsEVDKKLKRKKQVA |
| P55036 | S266 | Sugiyama | PSMD4 MCB1 | AGIATTGtEDsDDALLKMtIsQQEFGRTGLPDLSSMTEEEQ |
| P55735 | S184 | Sugiyama | SEC13 D3S1231E SEC13A SEC13L1 SEC13R | PGsLIDHPSGQKPNYIKRFAsGGCDNLIKLWKEEEDGQWKE |
| P55795 | S269 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQstTGH |
| P57772 | S28 | Sugiyama | EEFSEC SELB | VNVGVLGHIDSGKTALARALsTTASTAAFDKQPQSRERGIT |
| P60468 | S49 | Sugiyama | SEC61B | STVRQRKNASCGTRSAGRtTsAGTGGMWRFYTEDSPGLKVG |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S365 | Sugiyama | ACTB | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P60900 | S175 | Sugiyama | PSMA6 PROS27 | DPAGyyCGFKATAAGVKQtEstsFLEKKVKKKFDWTFEQTV |
| P61221 | Y594 | Sugiyama | ABCE1 RLI RNASEL1 RNASELI RNS4I OK/SW-cl.40 | RPRINKLNsIKDVEQKKsGNyFFLDD_______________ |
| P61247 | S203 | Sugiyama | RPS3A FTE1 MFTL | EVVNKLIPDsIGKDIEKACQsIyPLHDVFVRKVKMLKKPKF |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S238 | Sugiyama | RPS3A FTE1 MFTL | LKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyEP |
| P61254 | S9 | Sugiyama | RPL26 | ____________MKFNPFVtsDRsKNRKRHFNAPsHIRRKI |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61313 | S118 | Sugiyama | RPL15 EC45 TCBAP0781 | LQsVAEERAGRHCGALRVLNsyWVGEDSTyKFFEVILIDPF |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61981 | S64 | Sugiyama | YWHAG | LLsVAyKNVVGARRSsWRVIsSIEQKtsADGNEKKIEMVRA |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | S67 | Sugiyama | RPS11 | PKEAIEGtyIDKKCPFTGNVsIRGRILsGVVTKMKMQRTIV |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62826 | T32 | Sugiyama | RAN ARA24 OK/SW-cl.81 | KLVLVGDGGtGKttFVKRHLtGEFEKKyVATLGVEVHPLVF |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62937 | S51 | Sugiyama | PPIA CYPA | KtAENFRALSTGEKGFGYKGsCFHRIIPGFMCQGGDFtRHN |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S365 | Sugiyama | ACTG1 ACTG | ILAsLstFQQMWISKQEyDEsGPsIVHRKCF__________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P78371 | S470 | Sugiyama | CCT2 99D8.1 CCTB | IADNAGYDSADLVAQLRAAHsEGNttAGLDMREGTIGDMAI |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q02539 | S92 | Sugiyama | H1-1 H1F1 HIST1H1A | AGyDVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNK |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02880 | S1522 | Sugiyama | TOP2B | DTVPKPKRAPKQKKVVEAVNsDsDsEFGIPKKTTtPKGKGR |
| Q04917 | S64 | Sugiyama | YWHAH YWHA1 | LLsVAyKNVVGARRSsWRVIsSIEQKTMADGNEKKLEKVKA |
| Q05397 | S677 | Sugiyama | PTK2 FAK FAK1 | KCWAYDPSRRPRFTELKAQLsTILEEEKAQQEERMRMEsRR |
| Q07157 | S585 | Sugiyama | TJP1 ZO1 | NHKEVERGIIPNKNRAEQLAsVQytLPKTAGGDRADFWRFR |
| Q07666 | S35 | Sugiyama | KHDRBS1 SAM68 | sGRsGsMDPsGAHPsVRQtPsRQPPLPHRSRGGGGGSRGGA |
| Q08211 | S1026 | Sugiyama | DHX9 DDX9 LKP NDH2 | HKEKRKILTTEGRNALIHKssVNCPFssQDMKYPSPFFVFG |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q12906 | S19 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | __MRPMRIFVNDDRHVMAKHssVyPTQEELEAVQNMVsHtE |
| Q13085 | S1766 | Sugiyama | ACACA ACAC ACC1 ACCA | KGYRYLYLTPQDYKRVsALNsVHCEHVEDEGESRYKITDII |
| Q13263 | S471 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | FGsGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLE |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q13573 | S234 | Sugiyama | SNW1 SKIIP SKIP | INKKIPRGPPsPPAPVMHsPsRKMTVKEQQEWKIPPCISNW |
| Q13596 | S229 | Sugiyama | SNX1 | PPPPEKSLIGMTKVKVGKEDsssAEFLEKRRAALERYLQRI |
| Q13596 | S231 | Sugiyama | SNX1 | PPEKSLIGMTKVKVGKEDsssAEFLEKRRAALERYLQRIVN |
| Q13596 | S368 | Sugiyama | SNX1 | AKSLAMLGSSEDNTALSRALsQLAEVEEKIEQLHQEQANND |
| Q13625 | T739 | Sugiyama | TP53BP2 ASPP2 BBP | EALRKKLSNAPRPLKKRssItEPEGPNGPNIQKLLYQRTTI |
| Q13769 | S314 | Sugiyama | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q14126 | S551 | Sugiyama | DSG2 CDHF5 | FSVIDKPPGMAEKWKIARQEstsVLLQQSEKKLGRSEIQFL |
| Q14152 | S1028 | Sugiyama | EIF3A EIF3S10 KIAA0139 | NWRHADDDRPPRRGLDEDRGsWRtADEDRGPRRGMDDDRGP |
| Q14152 | S1257 | Sugiyama | EIF3A EIF3S10 KIAA0139 | DRFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRER |
| Q14152 | S1258 | Sugiyama | EIF3A EIF3S10 KIAA0139 | RFRRPRDEGGWRRGPAEEsssWRDssRRDDRDRDDRRRERD |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14160 | S493 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | RAtPHPSELKVMKRSIEGRRsEACPCQPDsGsPLPAEEEKR |
| Q14204 | S2384 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | FSEDVLSTDMIFNNFLARLRsIPLDEGEDEAQRRRKGKEDE |
| Q14247 | S298 | PSP | CTTN EMS1 | ERQDsAAVGFDyKEKLAKHEsQQDySKGFGGKyGVQKDRMD |
| Q14257 | S37 | Sugiyama | RCN2 ERC55 | AAAAGAGKAEELHyPLGERRsDyDREALLGVQEDVDEyVKL |
| Q14320 | S50 | Sugiyama | FAM50A DXS9928E HXC26 XAP5 | QMKQRIAEENIMKSNIDKKFsAHyDAVEAELKsstVGLVtL |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14966 | S1228 | Sugiyama | ZNF638 NP220 ZFML | DLEKKGAEIINPKTALLPSDsVFAEERNLKGILEEsPsEAE |
| Q14978 | S456 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | EKTKKMVATTKPKATAKAALsLPAKQAPQGSRDSSSDSDSS |
| Q15021 | S1333 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | APsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHPNTQ |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15139 | S397 | Sugiyama | PRKD1 PKD PKD1 PRKCM | NDSGEMQDPDPDHEDANRtIsPstsNNIPLMRVVQsVKHTK |
| Q15139 | S399 | Sugiyama | PRKD1 PKD PKD1 PRKCM | SGEMQDPDPDHEDANRtIsPstsNNIPLMRVVQsVKHTKRK |
| Q15139 | S401 | Sugiyama | PRKD1 PKD PKD1 PRKCM | EMQDPDPDHEDANRtIsPstsNNIPLMRVVQsVKHTKRKSs |
| Q15139 | S738 | EPSD|PSP | PRKD1 PKD PKD1 PRKCM | DPFPQVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNK |
| Q15139 | S742 | EPSD|PSP|Sugiyama | PRKD1 PKD PKD1 PRKCM | QVKLCDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNR |
| Q15139 | T746 | Sugiyama | PRKD1 PKD PKD1 PRKCM | CDFGFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNRSLDM |
| Q15139 | Y749 | Sugiyama | PRKD1 PKD PKD1 PRKCM | GFARIIGEKsFRRsVVGtPAyLAPEVLRNKGYNRSLDMWSV |
| Q15172 | S472 | Sugiyama | PPP2R5A | EELWKKLEELKLKKALEKQNsAyNMHSILSNTSAE______ |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15545 | S171 | Sugiyama | TAF7 TAF2F TAFII55 | TAKKKYIEsPDVEKEVKRLLstDAEAVSTRWEIIAEDETKE |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q16204 | S323 | Sugiyama | CCDC6 D10S170 TST1 | RLQRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQ |
| Q16204 | S325 | Sugiyama | CCDC6 D10S170 TST1 | QRKLQREMERREALCRQLsEsEssLEMDDERYFNEMsAQGL |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16576 | S163 | Sugiyama | RBBP7 RBAP46 | tPssDVLVFDyTKHPAKPDPsGECNPDLRLRGHQKEGYGLS |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3MII6 | S506 | Sugiyama | TBC1D25 OATL1 | DHLATASQGPGGGGRLLRQAsLDGLQQLRDNMGSRRDPLVQ |
| Q53EL6 | S82 | Sugiyama | PDCD4 H731 | RLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPKGRLLDR |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF7 | S185 | Sugiyama | HSP90AB3P HSP90BC | KEDQtEyLEERRVKEVVKKHsQFIGyPItLyLEKEQDKEIs |
| Q5RKV6 | S14 | Sugiyama | EXOSC6 MTR3 | _______MPGDHRRIRGPEEsQPPQLyAADEEEAPGTRDPT |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5VT52 | S1070 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETLGy |
| Q6DD87 | S104 | Sugiyama | ZNF787 | HQRTHtGERPNACADCGKTFsQSSHLVQHRRIHtGEKPYAC |
| Q6FI81 | T250 | Sugiyama | CIAPIN1 CUA001 PRO0915 | ASLRAASCGEGKKRKACKNCtCGLAEELEKEKSREQMSSQP |
| Q6S8J3 | S1065 | Sugiyama | POTEE A26C1A POTE2 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UX04 | S203 | Sugiyama | CWC27 SDCCAG10 UNQ438/PRO871 | KKEKPEEEVKKLKPKGTKNFsLLsFGEEAEEEEEEVNRVSQ |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q86UF2 | S140 | Sugiyama | CTAGE6 CTAGE6P | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q86UP2 | S1180 | Sugiyama | KTN1 CG1 KIAA0004 | EENKWKVKVDESHKTIKQMQssFTSsEQELERLRSENKDIE |
| Q86VQ1 | S206 | Sugiyama | GLCCI1 | PRDPHVHYPSCMKDKATQTPsCWAEEGAEKRSHQRsAsWGs |
| Q8IX94 | S140 | Sugiyama | CTAGE4 | AAAEEARSLEATCEKLNRsNsELEDEILCLEKDLKEEKSKH |
| Q8N129 | S45 | Sugiyama | CNPY4 PSEC0237 UNQ1909/PRO4354 | KEEDDDTERLPSKCEVCKLLstELQAELsRtGRsREVLELG |
| Q8N1G4 | T371 | Sugiyama | LRRC47 KIAA1185 | ALKRFLTSQTKLHEDLCEKRtAAtLAtHELRAVKGPLLYCA |
| Q8N1G4 | T374 | Sugiyama | LRRC47 KIAA1185 | RFLTSQTKLHEDLCEKRtAAtLAtHELRAVKGPLLYCARPP |
| Q8N8S7 | S125 | Sugiyama | ENAH MENA | MHALEVLNSQETGPTLPRQNsQLPAQVQNGPSQEELEIQRR |
| Q8NBP7 | S225 | Sugiyama | PCSK9 NARC1 PSEC0052 | FENVPEEDGTRFHRQASKCDsHGtHLAGVVSGRDAGVAKGA |
| Q8NEJ9 | S214 | Sugiyama | NGDN C14orf120 | ERAKRRALsSsVIRELKEQYsDAPEEIRDARHPHVTRQSQE |
| Q8NI08 | S208 | Sugiyama | NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 | DKLPDADLARKALKPIERVLsstsEEDEPGVVKFLKMNCRY |
| Q8NI08 | S441 | Sugiyama | NCOA7 ERAP140 ESNA1 Nbla00052 Nbla10993 | ELSsQTGGGMHKKDTLKECLsLDPEERKKAESQINNSAVEM |
| Q8TE77 | S37 | Sugiyama | SSH3 SSH3L | tPVGPWDQAVQRRSRLQRRQsFAVLRGAVLGLQDGGDNDDA |
| Q8WUI4 | S155 | SIGNOR | HDAC7 HDAC7A | PPVPSLPSDPPEHFPLRKtVsEPNLKLRYKPKKSLERRKNP |
| Q8WUI4 | S358 | SIGNOR | HDAC7 HDAC7A | LMTTERLSGSGLHWPLSRtRsEPLPPSATAPPPPGPMQPRL |
| Q8WUI4 | S405 | Sugiyama | HDAC7 HDAC7A | VQVIKRSAKPSEKPRLRQIPsAEDLEtDGGGPGQVVDDGLE |
| Q8WUI4 | S486 | Sugiyama | HDAC7 HDAC7A | GDtVLLPLAQGGHRPLsRAQssPAAPAsLSAPEPASQARVL |
| Q8WYL5 | S978 | SIGNOR | SSH1 KIAA1298 SSH1L | IETRLRLAGLTVssPLKRSHsLAKLGsLtFstEDLsSEADP |
| Q92625 | S663 | Sugiyama | ANKS1A ANKS1 KIAA0229 ODIN | sRsEsLsNCsIGKKRLEKsPsFAsEWDEIEKIMssIGEGID |
| Q96E11 | S239 | Sugiyama | MRRF | LKKSKDTVsEDtIRLIEKQIsQMADDtVAELDRHLAVKTKE |
| Q96G46 | T240 | Sugiyama | DUS3L | KREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPRQENC |
| Q96JJ7 | S268 | Sugiyama | TMX3 KIAA1830 TXNDC10 | LVALAVIDEKNTSVEHTRLKsIIQEVARDYRDLFHRDFQFG |
| Q96T37 | S344 | Sugiyama | RBM15 OTT OTT1 | PRDLERERDYPFYERVRPAYsLEPRVGAGAGAAPFREVDEI |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99575 | S816 | Sugiyama | POP1 KIAA0061 | VAATGSHLCVLRSRKLLKQLsAWCGPSSEDSRGGRRAPGRG |
| Q9BQ52 | S796 | Sugiyama | ELAC2 HPC2 | EEMEERREKRELRQVRAALLsRELAGGLEDGEPQQKRAHTE |
| Q9BXP5 | S422 | Sugiyama | SRRT ARS2 ASR2 | EKPKDAAGLECKPRPLHKTCsLFMRNIAPNISRAEIIsLCK |
| Q9BY44 | S528 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | DLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKAIE |
| Q9BYX7 | S365 | Sugiyama | POTEKP ACTBL3 FKSG30 | ILASLSTFQQMWISKQEyDEsGPsIVHRKCF__________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9C0C9 | S399 | Sugiyama | UBE2O KIAA1734 | EGsMAKKVKRLLKKQVVRIMsCsPDtQCsRDHsMEDPDKKG |
| Q9GZY8 | S155 | SIGNOR | MFF C2orf33 AD030 AD033 GL004 | PPttPQNEEIRAVGRLKRERsMsENAVRQNGQLVRNDsLWH |
| Q9GZY8 | S172 | SIGNOR|PSP | MFF C2orf33 AD030 AD033 GL004 | RERsMsENAVRQNGQLVRNDsLWHRsDsAPRNKISRFQAPI |
| Q9GZY8 | S275 | SIGNOR | MFF C2orf33 AD030 AD033 GL004 | RGGsAAAtsNPHHDNVRYGIsNIDTTIEGTSDDLTVVDAAS |
| Q9H0H5 | S206 | Sugiyama | RACGAP1 KIAA1478 MGCRACGAP | tsRQFVDGPPGPVKKtRsIGsAVDQGNEsIVAKTTVTVPND |
| Q9H3N1 | S270 | Sugiyama | TMX1 TMX TXNDC TXNDC1 PSEC0085 UNQ235/PRO268 | EAEsKEGtNKDFPQNAIRQRsLGPsLAtDKs__________ |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H788 | S316 | Sugiyama | SH2D4A PPP1R38 SH2A | NSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRAG |
| Q9H9Q2 | S225 | Sugiyama | COPS7B CSN7B | TQQQVEAEVTNIKKTLKAtAsSsAQEMEQQLAERECPPHAE |
| Q9H9Q2 | T223 | Sugiyama | COPS7B CSN7B | NRTQQQVEAEVTNIKKTLKAtAsSsAQEMEQQLAERECPPH |
| Q9HB07 | S196 | Sugiyama | MYG1 C12orf10 | DNGISQWAEGEPRyALttTLsARVARLNPTWNHPDQDTEAG |
| Q9NQ55 | S47 | Sugiyama | PPAN BXDC3 SSF1 | ANPHSFVFTRGCTGRNIRQLsLDVRRVMEPLTASRLQVRKK |
| Q9NR30 | S706 | Sugiyama | DDX21 | PTASVTEIQEKWHDSRRWQLsVATEQPELEGPREGYGGFRG |
| Q9NXH9 | S524 | Sugiyama | TRMT1 | KECPVKRERLsETsPAFRILsVEPRLQANFTIREDANPSSR |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UKV3 | S987 | Sugiyama | ACIN1 ACINUS KIAA0670 | EVKKVTLGDtLtRRsIsQQKsGVsITIDDPVRtAQVPsPPR |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9ULD2 | S1203 | Sugiyama | MTUS1 ATBP ATIP GK1 KIAA1288 MTSG1 | QENEELKARMDKHMAISRQLstEQAVLQESLEKESKVNKRL |
| Q9UMZ2 | S752 | Sugiyama | SYNRG AP1GBP1 SYNG | VKGGQNSTAASTKyDVFRQLsLEGsGLGVEDLKDNtPSGKs |
| Q9UNF1 | S264 | Sugiyama | MAGED2 BCG1 | sLRsPKARRGKARRRAAKLQssQEPEAPPPRDVALLQGRAN |
| Q9UNH7 | S55 | Sugiyama | SNX6 | DISDALSERDKVKFTVHTKSsLPNFKQNEFSVVRQHEEFIW |
| Q9UNX3 | S9 | Sugiyama | RPL26L1 RPL26P1 | ____________MKFNPFVtsDRsKNRKRHFNAPSHVRRKI |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UPN9 | S1015 | Sugiyama | TRIM33 KIAA1113 RFG7 TIF1G | KIIKKPMDLSTVKKKLQKKHsQHYQIPDDFVADVRLIFKNC |
| Q9UPY8 | S176 | Sugiyama | MAPRE3 | AVPQRtsPtGPKNMQTSGRLsNVAPPCILRKNPPSARNGGH |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQL6 | S259 | SIGNOR | HDAC5 KIAA0600 | KLPLPGPYDSRDDFPLRKTAsEPNLKVRSRLKQKVAERRss |
| Q9UQL6 | S498 | SIGNOR|EPSD|PSP | HDAC5 KIAA0600 | ATSMRTVGKLPRHRPLSRtQssPLPQSPQALQQLVMQQQHQ |
| Q9Y2B0 | T168 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | LIEFFsREADNVKDKLCSKRtDLCDHALHIsHDEL______ |
| Q9Y2X7 | S46 | SIGNOR|EPSD|PSP | GIT1 | RGVLVCDECCSVHRSLGRHIsIVKHLRHsAWPPTLLQMVHT |
| Q9Y3B8 | S203 | Sugiyama | REXO2 SFN SMFN CGI-114 | EYEFAPKKAAsHRALDDIsEsIKELQFyRNNIFKKKIDEKK |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y580 | S136 | Sugiyama | RBM7 | RyERTMDNMTSSAQIIQRsFssPENFQRQAVMNsALRQMSY |
| Q9Y5A9 | S394 | Sugiyama | YTHDF2 HGRG8 | SQAGSGStPSEPHPVLEKLRsINNYNPKDFDWNLKHGRVFI |
| Q9Y5B9 | S650 | Sugiyama | SUPT16H FACT140 FACTP140 | KRYKTREAEEKEKEGIVKQDsLVINLNRsNPKLKDLYIRPN |
| Q9Y618 | T35 | Sugiyama | NCOR2 CTG26 | TEPRYPPHSLSYPVQIARTHtDVGLLEYQHHSRDYASHLSP |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Attenuation phase | R-HSA-3371568 | 5.270686e-08 | 7.278 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 7.138640e-08 | 7.146 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.020336e-07 | 6.991 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.262095e-07 | 6.899 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.184246e-07 | 6.497 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.103945e-06 | 5.957 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.302254e-06 | 5.885 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.578078e-06 | 5.446 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.318383e-06 | 5.365 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.397939e-06 | 5.194 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 6.824158e-06 | 5.166 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.058066e-05 | 4.975 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.134910e-05 | 4.945 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.347046e-05 | 4.871 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.807741e-05 | 4.743 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 3.183818e-05 | 4.497 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 3.735872e-05 | 4.428 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.034054e-05 | 4.394 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.549336e-05 | 4.342 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.977784e-05 | 4.098 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.259113e-05 | 4.033 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.066861e-04 | 3.972 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.111899e-04 | 3.954 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.111899e-04 | 3.954 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.527187e-04 | 3.816 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.322557e-04 | 3.634 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 3.607739e-04 | 3.443 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.413640e-04 | 3.355 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.881247e-04 | 3.311 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.087711e-04 | 3.293 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 8.252450e-04 | 3.083 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.101314e-03 | 2.958 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.120939e-03 | 2.950 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.185181e-03 | 2.926 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.197214e-03 | 2.922 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.299181e-03 | 2.886 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.274675e-03 | 2.895 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.261780e-03 | 2.899 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 1.417989e-03 | 2.848 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 1.507335e-03 | 2.822 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.742916e-03 | 2.759 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.212338e-03 | 2.655 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.537381e-03 | 2.596 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.306001e-03 | 2.481 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.716804e-03 | 2.430 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.022683e-03 | 2.395 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.022683e-03 | 2.395 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.040092e-03 | 2.394 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.125105e-03 | 2.385 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.392812e-03 | 2.357 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.531466e-03 | 2.344 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 4.609313e-03 | 2.336 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.875596e-03 | 2.312 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.158352e-03 | 2.287 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.481771e-03 | 2.261 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 5.739576e-03 | 2.241 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.886510e-03 | 2.230 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.755320e-03 | 2.240 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.045297e-03 | 2.219 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.069706e-03 | 2.217 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 6.394459e-03 | 2.194 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.384485e-03 | 2.132 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 7.354534e-03 | 2.133 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 7.782698e-03 | 2.109 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.558518e-03 | 2.122 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.167617e-03 | 2.088 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.167617e-03 | 2.088 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.735724e-03 | 2.059 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 8.735724e-03 | 2.059 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 8.735724e-03 | 2.059 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 8.786383e-03 | 2.056 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 9.120398e-03 | 2.040 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.651796e-03 | 2.015 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.009364e-02 | 1.996 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.046076e-02 | 1.980 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.009364e-02 | 1.996 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.023942e-02 | 1.990 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.057849e-02 | 1.976 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.169624e-02 | 1.932 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.117057e-02 | 1.952 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.172707e-02 | 1.931 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.172707e-02 | 1.931 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.193107e-02 | 1.923 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.234716e-02 | 1.908 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.316819e-02 | 1.880 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.523716e-02 | 1.817 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.523716e-02 | 1.817 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.523716e-02 | 1.817 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.496005e-02 | 1.825 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.664556e-02 | 1.779 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.778065e-02 | 1.750 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.778065e-02 | 1.750 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.713150e-02 | 1.766 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.778065e-02 | 1.750 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.965806e-02 | 1.706 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.043830e-02 | 1.690 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 2.345379e-02 | 1.630 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.345379e-02 | 1.630 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.345379e-02 | 1.630 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 2.345379e-02 | 1.630 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.345379e-02 | 1.630 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.379477e-02 | 1.624 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.197367e-02 | 1.658 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.379477e-02 | 1.624 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.345379e-02 | 1.630 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.169739e-02 | 1.664 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.344287e-02 | 1.630 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.395305e-02 | 1.621 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.434193e-02 | 1.614 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.470815e-02 | 1.607 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.504949e-02 | 1.601 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.560592e-02 | 1.592 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.778635e-02 | 1.556 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.598845e-02 | 1.585 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.962459e-02 | 1.528 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.281110e-02 | 1.484 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.281110e-02 | 1.484 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.281110e-02 | 1.484 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.273134e-02 | 1.485 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.273134e-02 | 1.485 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.272747e-02 | 1.485 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.281110e-02 | 1.484 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.835045e-02 | 1.547 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 3.032796e-02 | 1.518 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.272747e-02 | 1.485 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 3.054233e-02 | 1.515 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.884025e-02 | 1.540 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 3.272747e-02 | 1.485 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.193239e-02 | 1.496 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.893210e-02 | 1.539 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.094869e-02 | 1.509 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.084629e-02 | 1.511 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.392415e-02 | 1.469 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.419086e-02 | 1.466 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 3.452464e-02 | 1.462 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.516569e-02 | 1.454 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.517818e-02 | 1.454 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.558998e-02 | 1.449 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 3.585004e-02 | 1.446 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 3.585004e-02 | 1.446 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.585004e-02 | 1.446 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.717194e-02 | 1.430 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.988300e-02 | 1.399 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.717194e-02 | 1.430 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 3.988300e-02 | 1.399 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 4.760137e-02 | 1.322 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.760137e-02 | 1.322 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.669506e-02 | 1.331 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.669506e-02 | 1.331 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.450527e-02 | 1.352 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 4.450527e-02 | 1.352 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.582978e-02 | 1.339 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.393794e-02 | 1.357 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.484909e-02 | 1.348 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 4.484909e-02 | 1.348 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.760137e-02 | 1.322 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.760137e-02 | 1.322 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.760137e-02 | 1.322 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.381783e-02 | 1.358 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.546907e-02 | 1.342 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.730352e-02 | 1.325 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.589408e-02 | 1.338 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 4.387382e-02 | 1.358 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.672627e-02 | 1.330 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 4.863324e-02 | 1.313 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 5.289996e-02 | 1.277 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.289996e-02 | 1.277 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.355544e-02 | 1.271 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.378788e-02 | 1.269 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.435980e-02 | 1.265 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.173354e-02 | 1.209 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.173354e-02 | 1.209 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.179151e-02 | 1.209 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.892233e-02 | 1.230 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.740671e-02 | 1.241 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.796149e-02 | 1.237 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.672289e-02 | 1.246 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.179151e-02 | 1.209 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.325042e-02 | 1.199 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 6.327369e-02 | 1.199 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.388407e-02 | 1.195 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 6.414468e-02 | 1.193 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.481594e-02 | 1.188 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 6.518181e-02 | 1.186 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 6.578883e-02 | 1.182 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.578883e-02 | 1.182 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 6.578883e-02 | 1.182 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 6.578883e-02 | 1.182 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 6.578883e-02 | 1.182 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 6.578883e-02 | 1.182 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 6.578883e-02 | 1.182 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.677232e-02 | 1.175 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.870983e-02 | 1.163 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.546786e-02 | 1.122 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.546786e-02 | 1.122 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 7.012404e-02 | 1.154 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.933452e-02 | 1.159 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 6.870983e-02 | 1.163 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 6.843911e-02 | 1.165 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.185842e-02 | 1.144 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.601914e-02 | 1.119 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.698323e-02 | 1.114 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 7.773141e-02 | 1.109 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.774096e-02 | 1.109 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.848497e-02 | 1.105 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.250441e-01 | 0.903 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.250441e-01 | 0.903 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.007635e-01 | 0.997 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.007635e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.007635e-01 | 0.997 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 1.007635e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.007635e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.007635e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.007635e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.007635e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.007635e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.007635e-01 | 0.997 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.007635e-01 | 0.997 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.007635e-01 | 0.997 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.344584e-01 | 0.630 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.344584e-01 | 0.630 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.344584e-01 | 0.630 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.344584e-01 | 0.630 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.344584e-01 | 0.630 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.344584e-01 | 0.630 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.344584e-01 | 0.630 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.344584e-01 | 0.630 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.344584e-01 | 0.630 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.344584e-01 | 0.630 | 0 | 0 |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | R-HSA-5619068 | 2.344584e-01 | 0.630 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.344584e-01 | 0.630 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.447053e-01 | 0.840 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 1.447053e-01 | 0.840 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.447053e-01 | 0.840 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 1.447053e-01 | 0.840 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 9.330109e-02 | 1.030 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 9.330109e-02 | 1.030 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.914603e-02 | 1.102 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.914603e-02 | 1.102 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.209415e-01 | 0.917 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.917215e-01 | 0.717 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.917215e-01 | 0.717 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 1.917215e-01 | 0.717 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.917215e-01 | 0.717 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.917215e-01 | 0.717 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.917215e-01 | 0.717 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.917215e-01 | 0.717 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.917215e-01 | 0.717 | 0 | 0 |
| FGFR4 mutant receptor activation | R-HSA-1839128 | 3.301960e-01 | 0.481 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 3.301960e-01 | 0.481 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.301960e-01 | 0.481 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.301960e-01 | 0.481 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.301960e-01 | 0.481 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.301960e-01 | 0.481 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.301960e-01 | 0.481 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 3.301960e-01 | 0.481 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.301960e-01 | 0.481 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.301960e-01 | 0.481 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.301960e-01 | 0.481 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.301960e-01 | 0.481 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 3.301960e-01 | 0.481 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.301960e-01 | 0.481 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.301960e-01 | 0.481 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.301960e-01 | 0.481 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.301960e-01 | 0.481 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.301960e-01 | 0.481 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.301960e-01 | 0.481 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.301960e-01 | 0.481 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.301960e-01 | 0.481 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.301960e-01 | 0.481 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.301960e-01 | 0.481 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.301960e-01 | 0.481 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.511557e-01 | 0.821 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.511557e-01 | 0.821 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.201452e-01 | 0.920 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.201452e-01 | 0.920 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.201452e-01 | 0.920 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.201452e-01 | 0.920 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.201452e-01 | 0.920 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.403570e-01 | 0.619 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.403570e-01 | 0.619 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.403570e-01 | 0.619 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.834554e-01 | 0.736 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.834554e-01 | 0.736 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.434543e-01 | 0.843 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.434543e-01 | 0.843 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.138349e-01 | 0.944 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.138349e-01 | 0.944 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.059243e-01 | 0.975 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.059243e-01 | 0.975 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.327666e-01 | 0.877 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.327666e-01 | 0.877 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.683692e-01 | 0.774 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.173610e-01 | 0.663 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.173610e-01 | 0.663 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.173610e-01 | 0.663 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.894724e-01 | 0.538 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.894724e-01 | 0.538 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.894724e-01 | 0.538 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.894724e-01 | 0.538 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.894724e-01 | 0.538 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.894724e-01 | 0.538 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.894724e-01 | 0.538 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.139656e-01 | 0.383 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.139656e-01 | 0.383 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.139656e-01 | 0.383 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.139656e-01 | 0.383 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.139656e-01 | 0.383 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.900003e-02 | 1.102 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.217569e-01 | 0.915 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.530019e-01 | 0.815 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.946694e-01 | 0.711 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.946694e-01 | 0.711 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 8.238487e-02 | 1.084 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.386797e-01 | 0.858 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.524156e-01 | 0.598 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.524156e-01 | 0.598 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.524156e-01 | 0.598 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 2.524156e-01 | 0.598 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 2.524156e-01 | 0.598 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.014881e-01 | 0.994 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 1.744256e-01 | 0.758 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.256668e-01 | 0.901 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.256668e-01 | 0.901 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.566292e-01 | 0.805 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.221268e-01 | 0.653 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.221268e-01 | 0.653 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.381876e-01 | 0.471 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.381876e-01 | 0.471 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.381876e-01 | 0.471 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.381876e-01 | 0.471 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.381876e-01 | 0.471 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.034046e-01 | 0.985 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.969116e-01 | 0.706 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 1.969116e-01 | 0.706 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.755324e-01 | 0.756 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.881956e-01 | 0.540 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 2.881956e-01 | 0.540 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 2.881956e-01 | 0.540 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.571509e-01 | 0.804 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.411790e-01 | 0.850 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.505126e-01 | 0.601 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 2.505126e-01 | 0.601 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.203266e-01 | 0.657 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.262105e-01 | 0.899 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 8.485531e-02 | 1.071 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.125803e-01 | 0.949 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.381572e-01 | 0.860 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.713294e-01 | 0.766 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.713294e-01 | 0.766 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.796013e-01 | 0.553 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.243157e-01 | 0.489 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 3.243157e-01 | 0.489 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.243157e-01 | 0.489 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 3.858349e-01 | 0.414 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.858349e-01 | 0.414 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.858349e-01 | 0.414 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.858349e-01 | 0.414 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.858349e-01 | 0.414 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.858349e-01 | 0.414 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.858349e-01 | 0.414 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.858349e-01 | 0.414 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.858349e-01 | 0.414 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 4.872627e-01 | 0.312 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.872627e-01 | 0.312 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.872627e-01 | 0.312 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.872627e-01 | 0.312 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.872627e-01 | 0.312 | 0 | 0 |
| Phenylketonuria | R-HSA-2160456 | 4.872627e-01 | 0.312 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.872627e-01 | 0.312 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.872627e-01 | 0.312 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.872627e-01 | 0.312 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.277812e-02 | 1.082 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.225086e-01 | 0.912 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.225086e-01 | 0.912 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.874069e-01 | 0.727 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.824879e-01 | 0.739 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.091757e-01 | 0.510 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.091757e-01 | 0.510 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.604329e-01 | 0.443 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 3.604329e-01 | 0.443 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.604329e-01 | 0.443 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.604329e-01 | 0.443 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.604329e-01 | 0.443 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.604329e-01 | 0.443 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.604329e-01 | 0.443 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.813466e-01 | 0.551 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.390294e-01 | 0.470 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.319197e-01 | 0.365 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.319197e-01 | 0.365 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.319197e-01 | 0.365 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.319197e-01 | 0.365 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.319197e-01 | 0.365 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.689052e-01 | 0.570 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.917284e-01 | 0.717 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.917284e-01 | 0.717 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 3.962466e-01 | 0.402 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.607781e-01 | 0.794 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.138515e-01 | 0.944 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.759798e-01 | 0.559 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.759798e-01 | 0.559 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.689698e-01 | 0.433 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.689698e-01 | 0.433 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.271954e-01 | 0.485 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.271954e-01 | 0.485 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.271954e-01 | 0.485 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.101995e-01 | 0.508 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.101995e-01 | 0.508 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.721613e-01 | 0.565 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 3.504930e-01 | 0.455 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.725960e-01 | 0.429 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.988192e-01 | 0.399 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.988192e-01 | 0.399 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 4.314986e-01 | 0.365 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 4.314986e-01 | 0.365 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.760879e-01 | 0.322 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.760879e-01 | 0.322 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.760879e-01 | 0.322 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.513961e-01 | 0.259 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.513961e-01 | 0.259 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.513961e-01 | 0.259 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.513961e-01 | 0.259 | 0 | 0 |
| betaKlotho-mediated ligand binding | R-HSA-1307965 | 5.513961e-01 | 0.259 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.513961e-01 | 0.259 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.513961e-01 | 0.259 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.284165e-01 | 0.641 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.284165e-01 | 0.641 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.986954e-01 | 0.399 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.284163e-01 | 0.368 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.284163e-01 | 0.368 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.284163e-01 | 0.368 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.284163e-01 | 0.368 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.284163e-01 | 0.368 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.693752e-01 | 0.771 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.809396e-01 | 0.551 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.659711e-01 | 0.332 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.659711e-01 | 0.332 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 4.659711e-01 | 0.332 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 4.659711e-01 | 0.332 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.659711e-01 | 0.332 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.721911e-01 | 0.429 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 4.576166e-01 | 0.339 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.576166e-01 | 0.339 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.180980e-01 | 0.286 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 5.180980e-01 | 0.286 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.180980e-01 | 0.286 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 5.180980e-01 | 0.286 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.169382e-01 | 0.380 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.495742e-01 | 0.603 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.504413e-01 | 0.346 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.504413e-01 | 0.346 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.504413e-01 | 0.346 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.504413e-01 | 0.346 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.655029e-01 | 0.437 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.461976e-01 | 0.461 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.294640e-01 | 0.639 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.440892e-01 | 0.353 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.383452e-01 | 0.358 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.383452e-01 | 0.358 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.383452e-01 | 0.358 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 4.862924e-01 | 0.313 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.758891e-01 | 0.322 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.758891e-01 | 0.322 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.758891e-01 | 0.322 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.758891e-01 | 0.322 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.758891e-01 | 0.322 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.143327e-01 | 0.289 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.318932e-01 | 0.274 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.318932e-01 | 0.274 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.577990e-01 | 0.254 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 6.075109e-01 | 0.216 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.075109e-01 | 0.216 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 6.075109e-01 | 0.216 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 6.075109e-01 | 0.216 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 6.075109e-01 | 0.216 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 6.075109e-01 | 0.216 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 6.075109e-01 | 0.216 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.075109e-01 | 0.216 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 6.075109e-01 | 0.216 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.369562e-01 | 0.360 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.663456e-01 | 0.331 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 5.125154e-01 | 0.290 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.255052e-01 | 0.279 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.255052e-01 | 0.279 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.255052e-01 | 0.279 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.255052e-01 | 0.279 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.346313e-01 | 0.272 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.495295e-01 | 0.260 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.495295e-01 | 0.260 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.495295e-01 | 0.260 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 5.232092e-01 | 0.281 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 5.386234e-01 | 0.269 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.681433e-01 | 0.246 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.681433e-01 | 0.246 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 5.681433e-01 | 0.246 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.681433e-01 | 0.246 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.951113e-01 | 0.225 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 5.951113e-01 | 0.225 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.951113e-01 | 0.225 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 5.623448e-01 | 0.250 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 5.623448e-01 | 0.250 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.623448e-01 | 0.250 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.623448e-01 | 0.250 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.612596e-01 | 0.251 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.678302e-01 | 0.246 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.929756e-01 | 0.227 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.937695e-01 | 0.226 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.957172e-01 | 0.225 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.957172e-01 | 0.225 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.981870e-01 | 0.223 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 6.009048e-01 | 0.221 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 6.183098e-01 | 0.209 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.177891e-01 | 0.209 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.215057e-01 | 0.207 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.300113e-01 | 0.201 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.300113e-01 | 0.201 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.016371e-01 | 0.993 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.811679e-01 | 0.742 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.815574e-01 | 0.550 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 6.270779e-01 | 0.203 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.559069e-01 | 0.807 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.059506e-01 | 0.392 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 5.630851e-01 | 0.249 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 5.630851e-01 | 0.249 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.439327e-02 | 1.074 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.258665e-01 | 0.279 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.837680e-01 | 0.315 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.120363e-01 | 0.385 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.689698e-01 | 0.433 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.217569e-01 | 0.915 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.505126e-01 | 0.601 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.962466e-01 | 0.402 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.059191e-01 | 0.514 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 5.346313e-01 | 0.272 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.235855e-01 | 0.373 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.576166e-01 | 0.339 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 5.092499e-01 | 0.293 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 3.337763e-01 | 0.477 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.284163e-01 | 0.368 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.948785e-02 | 1.048 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 3.596401e-01 | 0.444 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.455982e-01 | 0.461 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 4.120363e-01 | 0.385 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 4.120363e-01 | 0.385 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.268925e-01 | 0.897 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.530019e-01 | 0.815 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 8.571562e-02 | 1.067 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.102391e-01 | 0.677 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.589853e-01 | 0.587 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.811456e-01 | 0.551 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 3.733211e-01 | 0.428 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 4.120363e-01 | 0.385 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.986954e-01 | 0.399 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.206840e-01 | 0.207 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.530019e-01 | 0.815 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.243157e-01 | 0.489 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 8.277812e-02 | 1.082 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.973790e-01 | 0.401 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.555669e-01 | 0.255 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.623448e-01 | 0.250 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.936942e-01 | 0.226 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.551222e-01 | 0.809 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.734963e-01 | 0.428 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 2.505126e-01 | 0.601 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.312870e-01 | 0.480 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.284163e-01 | 0.368 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.334200e-01 | 0.632 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.693641e-01 | 0.328 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.352111e-01 | 0.475 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.551222e-01 | 0.809 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.596401e-01 | 0.444 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.832367e-01 | 0.417 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.184702e-01 | 0.209 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.623448e-01 | 0.250 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.914603e-02 | 1.102 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.524156e-01 | 0.598 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.262105e-01 | 0.899 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 8.968226e-02 | 1.047 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.712257e-01 | 0.327 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 5.279906e-01 | 0.277 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.446571e-01 | 0.264 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.162083e-01 | 0.287 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.420257e-01 | 0.848 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.636798e-01 | 0.579 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.636798e-01 | 0.579 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 3.091757e-01 | 0.510 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.411790e-01 | 0.850 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.712257e-01 | 0.327 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.930135e-01 | 0.533 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.894724e-01 | 0.538 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 2.894724e-01 | 0.538 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.744256e-01 | 0.758 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.858349e-01 | 0.414 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.573438e-01 | 0.589 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.962466e-01 | 0.402 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.314986e-01 | 0.365 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 4.760879e-01 | 0.322 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.180980e-01 | 0.286 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 4.596271e-01 | 0.338 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.222164e-01 | 0.374 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 5.577990e-01 | 0.254 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.192573e-01 | 0.378 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.559069e-01 | 0.807 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.689698e-01 | 0.433 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.101995e-01 | 0.508 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.383452e-01 | 0.358 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.383452e-01 | 0.358 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.255052e-01 | 0.279 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 5.987804e-01 | 0.223 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.173610e-01 | 0.663 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.507240e-01 | 0.822 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.613227e-01 | 0.792 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 3.224663e-01 | 0.492 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.862924e-01 | 0.313 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.023736e-01 | 0.299 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.628536e-01 | 0.250 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.177891e-01 | 0.209 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.439201e-02 | 1.025 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 1.824879e-01 | 0.739 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 5.125154e-01 | 0.290 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.046375e-02 | 1.044 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.363644e-01 | 0.865 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.914603e-02 | 1.102 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.917215e-01 | 0.717 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.834554e-01 | 0.736 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.834554e-01 | 0.736 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.327666e-01 | 0.877 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.173610e-01 | 0.663 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.411790e-01 | 0.850 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.243157e-01 | 0.489 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.604329e-01 | 0.443 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.319197e-01 | 0.365 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 3.962466e-01 | 0.402 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.760879e-01 | 0.322 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 4.659711e-01 | 0.332 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.666818e-01 | 0.247 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.728916e-01 | 0.242 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 5.957172e-01 | 0.225 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 6.300113e-01 | 0.201 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 3.707282e-01 | 0.431 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.826625e-01 | 0.316 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.826625e-01 | 0.316 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 5.306588e-01 | 0.275 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.709127e-01 | 0.431 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.282998e-01 | 0.368 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.924222e-01 | 0.227 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.589853e-01 | 0.587 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.348240e-01 | 0.272 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.524156e-01 | 0.598 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.918367e-01 | 0.717 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 1.918367e-01 | 0.717 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.604329e-01 | 0.443 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.041152e-01 | 0.517 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.017257e-01 | 0.520 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.671846e-01 | 0.331 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.807283e-01 | 0.318 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 6.037361e-01 | 0.219 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.117074e-01 | 0.213 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 3.962466e-01 | 0.402 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.563111e-01 | 0.255 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 8.485531e-02 | 1.071 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.670512e-01 | 0.573 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.357062e-01 | 0.867 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 3.131166e-01 | 0.504 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.815574e-01 | 0.550 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.235223e-01 | 0.373 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 3.107525e-01 | 0.508 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.511557e-01 | 0.821 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 9.630853e-02 | 1.016 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.173610e-01 | 0.663 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.381876e-01 | 0.471 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.713294e-01 | 0.766 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.506742e-01 | 0.822 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.091757e-01 | 0.510 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.047439e-01 | 0.689 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.047439e-01 | 0.689 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.047439e-01 | 0.689 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.047439e-01 | 0.689 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 3.962466e-01 | 0.402 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.988192e-01 | 0.399 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 3.986954e-01 | 0.399 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.207960e-01 | 0.376 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.897495e-01 | 0.409 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.577990e-01 | 0.254 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 6.075109e-01 | 0.216 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.369562e-01 | 0.360 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.630851e-01 | 0.249 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.630851e-01 | 0.249 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.957172e-01 | 0.225 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.981870e-01 | 0.223 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 9.309002e-02 | 1.031 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.427949e-01 | 0.354 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.845447e-01 | 0.233 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.854285e-01 | 0.314 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.694211e-01 | 0.570 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.879382e-01 | 0.231 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.409832e-01 | 0.851 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 6.229601e-01 | 0.206 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.739884e-01 | 0.427 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.440892e-01 | 0.353 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.505126e-01 | 0.601 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 2.459501e-01 | 0.609 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.184702e-01 | 0.209 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 2.855028e-01 | 0.544 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 5.929756e-01 | 0.227 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.796013e-01 | 0.553 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 3.962466e-01 | 0.402 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.271954e-01 | 0.485 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.690120e-01 | 0.329 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.300113e-01 | 0.201 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 5.937695e-01 | 0.226 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.025101e-01 | 0.395 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.780123e-01 | 0.238 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.780123e-01 | 0.238 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.574402e-01 | 0.340 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.900146e-01 | 0.721 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 9.330109e-02 | 1.030 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.524156e-01 | 0.598 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.755324e-01 | 0.756 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 4.872627e-01 | 0.312 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.319197e-01 | 0.365 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.513961e-01 | 0.259 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.207960e-01 | 0.376 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.207960e-01 | 0.376 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.075109e-01 | 0.216 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 5.527293e-01 | 0.257 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 5.818414e-01 | 0.235 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 3.201674e-01 | 0.495 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.636798e-01 | 0.579 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 4.650497e-01 | 0.333 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.201674e-01 | 0.495 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.262105e-01 | 0.899 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 4.119234e-01 | 0.385 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.407320e-01 | 0.618 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.937695e-01 | 0.226 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.543068e-01 | 0.343 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.921376e-01 | 0.716 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 4.514849e-01 | 0.345 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.434543e-01 | 0.843 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 9.110682e-02 | 1.040 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.278693e-01 | 0.369 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.261171e-01 | 0.370 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.981870e-01 | 0.223 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.841084e-01 | 0.416 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.507240e-01 | 0.822 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.059243e-01 | 0.975 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.760879e-01 | 0.322 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 4.994842e-01 | 0.301 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.211083e-01 | 0.207 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.461599e-01 | 0.609 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.335242e-01 | 0.874 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.795267e-01 | 0.746 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.388631e-01 | 0.358 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.681433e-01 | 0.246 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 8.146022e-02 | 1.089 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.567976e-01 | 0.590 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.390763e-01 | 0.621 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.390294e-01 | 0.470 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.957172e-01 | 0.225 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.249695e-01 | 0.204 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.813466e-01 | 0.551 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.270779e-01 | 0.203 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.868397e-01 | 0.542 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.344584e-01 | 0.630 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.344584e-01 | 0.630 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 2.403570e-01 | 0.619 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.434543e-01 | 0.843 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.434543e-01 | 0.843 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 2.894724e-01 | 0.538 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 4.139656e-01 | 0.383 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.139656e-01 | 0.383 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.139656e-01 | 0.383 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 4.139656e-01 | 0.383 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 4.139656e-01 | 0.383 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.969116e-01 | 0.706 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.969116e-01 | 0.706 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 2.881956e-01 | 0.540 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.445327e-01 | 0.612 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 2.796013e-01 | 0.553 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 2.796013e-01 | 0.553 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 3.858349e-01 | 0.414 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.872627e-01 | 0.312 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.551222e-01 | 0.809 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.604329e-01 | 0.443 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 4.319197e-01 | 0.365 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.689698e-01 | 0.433 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.513961e-01 | 0.259 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.246784e-01 | 0.372 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 3.196528e-01 | 0.495 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.576166e-01 | 0.339 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 4.169382e-01 | 0.380 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 5.577990e-01 | 0.254 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 6.075109e-01 | 0.216 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.075109e-01 | 0.216 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 6.075109e-01 | 0.216 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.075109e-01 | 0.216 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.951113e-01 | 0.225 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 5.951113e-01 | 0.225 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.775095e-01 | 0.238 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.981870e-01 | 0.223 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.009048e-01 | 0.221 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.184702e-01 | 0.209 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.470460e-01 | 0.607 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.818304e-01 | 0.550 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.957172e-01 | 0.225 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.015967e-01 | 0.300 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.515773e-01 | 0.454 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.525731e-01 | 0.453 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.371280e-01 | 0.625 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.940699e-01 | 0.226 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.636798e-01 | 0.579 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 9.970560e-02 | 1.001 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 2.844908e-01 | 0.546 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.977711e-01 | 0.704 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.158709e-01 | 0.666 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.416428e-01 | 0.266 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.739167e-01 | 0.427 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.677852e-01 | 0.775 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.818414e-01 | 0.235 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.818414e-01 | 0.235 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.818414e-01 | 0.235 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 3.525565e-01 | 0.453 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 3.525565e-01 | 0.453 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.859263e-01 | 0.313 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.690120e-01 | 0.329 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.864791e-02 | 1.006 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.319197e-01 | 0.365 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.180980e-01 | 0.286 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.318932e-01 | 0.274 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.415995e-01 | 0.355 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.184702e-01 | 0.209 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.005824e-01 | 0.522 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.207960e-01 | 0.376 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.015967e-01 | 0.300 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.612596e-01 | 0.251 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.411790e-01 | 0.850 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.210455e-01 | 0.656 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.019251e-01 | 0.992 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.403570e-01 | 0.619 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.173610e-01 | 0.663 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.894724e-01 | 0.538 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.319197e-01 | 0.365 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.674538e-01 | 0.776 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.760879e-01 | 0.322 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 5.513961e-01 | 0.259 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.284163e-01 | 0.368 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 4.576166e-01 | 0.339 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.180980e-01 | 0.286 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.577990e-01 | 0.254 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.577990e-01 | 0.254 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.075109e-01 | 0.216 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.201100e-01 | 0.284 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.177891e-01 | 0.209 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.899133e-01 | 0.229 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.047439e-01 | 0.689 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.096020e-01 | 0.293 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.196235e-01 | 0.377 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.205930e-01 | 0.494 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.238487e-02 | 1.084 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 3.504091e-01 | 0.455 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 9.123486e-02 | 1.040 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.318932e-01 | 0.274 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 4.192573e-01 | 0.378 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.205048e-01 | 0.494 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.041152e-01 | 0.517 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.691284e-01 | 0.433 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 5.125154e-01 | 0.290 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.504413e-01 | 0.346 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.295877e-01 | 0.887 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.139656e-01 | 0.383 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.524156e-01 | 0.598 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.881956e-01 | 0.540 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 2.881956e-01 | 0.540 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 4.872627e-01 | 0.312 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 2.813466e-01 | 0.551 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.573438e-01 | 0.589 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 3.962466e-01 | 0.402 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.271954e-01 | 0.485 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.797452e-01 | 0.745 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.513961e-01 | 0.259 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.513961e-01 | 0.259 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.180980e-01 | 0.286 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.180980e-01 | 0.286 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 5.318932e-01 | 0.274 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 5.577990e-01 | 0.254 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 6.075109e-01 | 0.216 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.075109e-01 | 0.216 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.681433e-01 | 0.246 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.951113e-01 | 0.225 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 5.859688e-01 | 0.232 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 6.184702e-01 | 0.209 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.651404e-01 | 0.782 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.183098e-01 | 0.209 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.048252e-01 | 0.516 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.215057e-01 | 0.207 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 1.890239e-01 | 0.723 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.797452e-01 | 0.745 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.553900e-01 | 0.255 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.853954e-01 | 0.233 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 5.877933e-01 | 0.231 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.872627e-01 | 0.312 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.102391e-01 | 0.677 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 1.176624e-01 | 0.929 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 3.464924e-01 | 0.460 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.659711e-01 | 0.332 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.818414e-01 | 0.235 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.279663e-01 | 0.277 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.981870e-01 | 0.223 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 2.403570e-01 | 0.619 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.139656e-01 | 0.383 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.858349e-01 | 0.414 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 4.872627e-01 | 0.312 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.319197e-01 | 0.365 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.319197e-01 | 0.365 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.513961e-01 | 0.259 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 6.300113e-01 | 0.201 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.203266e-01 | 0.657 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.796013e-01 | 0.553 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.217569e-01 | 0.915 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.246784e-01 | 0.372 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.937695e-01 | 0.226 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.630851e-01 | 0.249 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.300113e-01 | 0.201 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.493470e-01 | 0.260 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.215057e-01 | 0.207 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.255052e-01 | 0.279 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 5.630851e-01 | 0.249 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 5.951113e-01 | 0.225 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 6.300113e-01 | 0.201 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 6.300113e-01 | 0.201 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 6.300113e-01 | 0.201 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.850051e-01 | 0.733 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.604329e-01 | 0.443 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.576166e-01 | 0.339 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.929756e-01 | 0.227 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.929756e-01 | 0.227 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.671846e-01 | 0.331 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 4.314986e-01 | 0.365 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.143327e-01 | 0.289 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 5.125154e-01 | 0.290 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.577990e-01 | 0.254 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 5.775095e-01 | 0.238 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.300113e-01 | 0.201 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.354310e-01 | 0.474 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.314986e-01 | 0.365 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.180980e-01 | 0.286 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.176343e-01 | 0.286 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 5.143327e-01 | 0.289 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.929756e-01 | 0.227 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.376233e-01 | 0.195 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.376233e-01 | 0.195 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.378490e-01 | 0.195 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.378490e-01 | 0.195 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.378490e-01 | 0.195 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.378490e-01 | 0.195 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.380647e-01 | 0.195 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 6.381791e-01 | 0.195 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.389468e-01 | 0.195 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.391322e-01 | 0.194 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.391322e-01 | 0.194 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.391322e-01 | 0.194 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.401298e-01 | 0.194 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.409200e-01 | 0.193 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 6.422065e-01 | 0.192 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.422065e-01 | 0.192 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.468660e-01 | 0.189 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.486383e-01 | 0.188 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.486383e-01 | 0.188 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.549526e-01 | 0.184 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.552334e-01 | 0.184 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 6.552774e-01 | 0.184 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.556632e-01 | 0.183 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.566093e-01 | 0.183 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.566093e-01 | 0.183 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.566093e-01 | 0.183 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.566093e-01 | 0.183 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.566093e-01 | 0.183 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.566093e-01 | 0.183 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.566093e-01 | 0.183 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.566093e-01 | 0.183 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.566093e-01 | 0.183 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 6.566093e-01 | 0.183 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.566093e-01 | 0.183 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.566093e-01 | 0.183 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.566093e-01 | 0.183 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.566093e-01 | 0.183 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.566093e-01 | 0.183 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 6.566093e-01 | 0.183 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.566093e-01 | 0.183 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.566093e-01 | 0.183 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.566093e-01 | 0.183 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.566093e-01 | 0.183 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.566093e-01 | 0.183 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 6.589610e-01 | 0.181 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.597199e-01 | 0.181 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.597199e-01 | 0.181 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.597199e-01 | 0.181 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 6.625185e-01 | 0.179 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.625185e-01 | 0.179 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.625185e-01 | 0.179 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.625185e-01 | 0.179 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.625185e-01 | 0.179 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.625185e-01 | 0.179 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.625185e-01 | 0.179 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 6.625185e-01 | 0.179 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.625185e-01 | 0.179 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 6.625185e-01 | 0.179 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.625185e-01 | 0.179 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.625185e-01 | 0.179 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 6.625185e-01 | 0.179 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.625185e-01 | 0.179 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.625185e-01 | 0.179 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.667374e-01 | 0.176 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.694256e-01 | 0.174 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.694888e-01 | 0.174 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 6.706606e-01 | 0.173 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.710736e-01 | 0.173 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 6.712445e-01 | 0.173 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.732115e-01 | 0.172 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 6.743559e-01 | 0.171 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.743559e-01 | 0.171 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.743559e-01 | 0.171 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.743559e-01 | 0.171 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.743559e-01 | 0.171 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.743559e-01 | 0.171 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.750879e-01 | 0.171 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.795329e-01 | 0.168 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.795329e-01 | 0.168 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.795329e-01 | 0.168 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.795329e-01 | 0.168 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.829899e-01 | 0.166 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.862721e-01 | 0.164 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 6.866877e-01 | 0.163 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.866877e-01 | 0.163 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.866877e-01 | 0.163 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 6.866877e-01 | 0.163 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.866877e-01 | 0.163 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.866877e-01 | 0.163 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.926855e-01 | 0.159 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.926855e-01 | 0.159 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.926855e-01 | 0.159 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.926855e-01 | 0.159 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.926855e-01 | 0.159 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 6.926855e-01 | 0.159 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.926855e-01 | 0.159 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 6.926855e-01 | 0.159 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 6.926855e-01 | 0.159 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.965959e-01 | 0.157 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 6.985578e-01 | 0.156 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.985578e-01 | 0.156 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.986571e-01 | 0.156 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.986571e-01 | 0.156 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.986571e-01 | 0.156 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.986571e-01 | 0.156 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.989270e-01 | 0.156 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.995682e-01 | 0.155 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.995682e-01 | 0.155 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.995682e-01 | 0.155 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 6.995682e-01 | 0.155 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 6.995682e-01 | 0.155 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.995682e-01 | 0.155 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.995682e-01 | 0.155 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.995682e-01 | 0.155 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 6.995682e-01 | 0.155 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.995682e-01 | 0.155 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.014118e-01 | 0.154 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.048727e-01 | 0.152 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.048727e-01 | 0.152 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.048727e-01 | 0.152 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.065106e-01 | 0.151 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.065662e-01 | 0.151 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.074078e-01 | 0.150 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.074078e-01 | 0.150 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.074078e-01 | 0.150 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 7.074078e-01 | 0.150 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.097716e-01 | 0.149 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 7.097716e-01 | 0.149 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 7.097716e-01 | 0.149 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.129447e-01 | 0.147 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.167873e-01 | 0.145 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 7.169292e-01 | 0.145 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 7.203205e-01 | 0.142 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.205890e-01 | 0.142 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 7.205890e-01 | 0.142 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.205890e-01 | 0.142 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.205890e-01 | 0.142 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.205890e-01 | 0.142 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.205890e-01 | 0.142 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.205890e-01 | 0.142 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.205890e-01 | 0.142 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.205890e-01 | 0.142 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 7.205890e-01 | 0.142 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.205890e-01 | 0.142 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.205890e-01 | 0.142 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.205890e-01 | 0.142 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.207999e-01 | 0.142 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.215543e-01 | 0.142 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.215543e-01 | 0.142 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 7.215543e-01 | 0.142 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.215543e-01 | 0.142 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 7.215543e-01 | 0.142 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.215543e-01 | 0.142 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.215543e-01 | 0.142 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.261329e-01 | 0.139 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.261329e-01 | 0.139 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 7.261329e-01 | 0.139 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.264896e-01 | 0.139 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.264896e-01 | 0.139 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.271119e-01 | 0.138 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.271119e-01 | 0.138 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.271119e-01 | 0.138 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 7.271119e-01 | 0.138 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.271119e-01 | 0.138 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 7.302465e-01 | 0.137 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 7.342193e-01 | 0.134 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 7.352091e-01 | 0.134 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 7.352091e-01 | 0.134 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 7.362326e-01 | 0.133 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.371550e-01 | 0.132 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.371550e-01 | 0.132 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.371550e-01 | 0.132 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.371550e-01 | 0.132 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.371550e-01 | 0.132 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.371550e-01 | 0.132 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.371550e-01 | 0.132 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.371550e-01 | 0.132 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.371550e-01 | 0.132 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.371550e-01 | 0.132 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.371550e-01 | 0.132 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.371550e-01 | 0.132 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 7.371550e-01 | 0.132 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.371550e-01 | 0.132 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.371550e-01 | 0.132 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.371550e-01 | 0.132 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.371550e-01 | 0.132 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.394844e-01 | 0.131 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.429481e-01 | 0.129 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.430714e-01 | 0.129 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.430714e-01 | 0.129 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.430714e-01 | 0.129 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 7.430714e-01 | 0.129 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 7.430714e-01 | 0.129 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.439328e-01 | 0.128 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.439328e-01 | 0.128 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.458076e-01 | 0.127 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 7.458076e-01 | 0.127 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.463230e-01 | 0.127 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.463230e-01 | 0.127 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.463230e-01 | 0.127 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.463230e-01 | 0.127 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 7.463230e-01 | 0.127 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 7.463230e-01 | 0.127 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 7.463230e-01 | 0.127 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 7.463230e-01 | 0.127 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.463230e-01 | 0.127 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.463230e-01 | 0.127 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.463230e-01 | 0.127 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 7.463230e-01 | 0.127 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.463230e-01 | 0.127 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.484288e-01 | 0.126 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.484413e-01 | 0.126 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 7.495365e-01 | 0.125 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.495365e-01 | 0.125 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.499060e-01 | 0.125 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.499060e-01 | 0.125 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.508563e-01 | 0.124 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 7.522816e-01 | 0.124 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.557195e-01 | 0.122 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.632416e-01 | 0.117 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.632416e-01 | 0.117 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.632416e-01 | 0.117 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.632416e-01 | 0.117 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.633033e-01 | 0.117 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.635084e-01 | 0.117 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 7.637426e-01 | 0.117 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.667050e-01 | 0.115 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.667050e-01 | 0.115 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.699936e-01 | 0.114 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.699936e-01 | 0.114 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 7.699936e-01 | 0.114 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.699936e-01 | 0.114 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.699936e-01 | 0.114 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.699936e-01 | 0.114 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 7.699936e-01 | 0.114 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.699936e-01 | 0.114 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.700413e-01 | 0.113 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.700413e-01 | 0.113 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.700413e-01 | 0.113 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.700413e-01 | 0.113 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.700413e-01 | 0.113 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.700413e-01 | 0.113 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.700413e-01 | 0.113 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 7.700413e-01 | 0.113 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.700413e-01 | 0.113 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.700413e-01 | 0.113 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.700413e-01 | 0.113 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.700413e-01 | 0.113 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.700413e-01 | 0.113 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.726409e-01 | 0.112 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 7.765123e-01 | 0.110 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.802334e-01 | 0.108 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 7.816385e-01 | 0.107 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.817760e-01 | 0.107 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.821057e-01 | 0.107 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.821057e-01 | 0.107 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.821258e-01 | 0.107 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.821258e-01 | 0.107 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.850223e-01 | 0.105 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.891681e-01 | 0.103 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.891681e-01 | 0.103 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 7.916498e-01 | 0.101 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.917141e-01 | 0.101 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.917141e-01 | 0.101 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 7.917141e-01 | 0.101 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 7.917141e-01 | 0.101 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 7.917141e-01 | 0.101 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 7.917141e-01 | 0.101 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.943606e-01 | 0.100 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.960057e-01 | 0.099 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 7.960057e-01 | 0.099 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.960057e-01 | 0.099 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.960057e-01 | 0.099 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.960829e-01 | 0.099 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 7.988147e-01 | 0.098 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.988147e-01 | 0.098 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.988147e-01 | 0.098 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.988147e-01 | 0.098 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.988147e-01 | 0.098 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.988147e-01 | 0.098 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.988147e-01 | 0.098 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.988147e-01 | 0.098 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 7.988147e-01 | 0.098 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.988147e-01 | 0.098 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.988147e-01 | 0.098 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.997101e-01 | 0.097 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 7.997101e-01 | 0.097 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.008735e-01 | 0.096 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 8.012775e-01 | 0.096 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.086092e-01 | 0.092 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.106152e-01 | 0.091 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.106152e-01 | 0.091 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.106152e-01 | 0.091 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.108524e-01 | 0.091 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 8.116019e-01 | 0.091 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.116019e-01 | 0.091 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.116019e-01 | 0.091 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.116019e-01 | 0.091 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.116019e-01 | 0.091 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.116019e-01 | 0.091 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.120446e-01 | 0.090 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.128487e-01 | 0.090 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.128487e-01 | 0.090 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.161057e-01 | 0.088 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.161057e-01 | 0.088 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.161057e-01 | 0.088 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.161057e-01 | 0.088 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 8.200901e-01 | 0.086 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 8.224728e-01 | 0.085 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.224728e-01 | 0.085 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.224816e-01 | 0.085 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.238914e-01 | 0.084 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.239892e-01 | 0.084 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.239892e-01 | 0.084 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 8.239892e-01 | 0.084 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.239892e-01 | 0.084 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 8.239892e-01 | 0.084 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.239892e-01 | 0.084 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.239892e-01 | 0.084 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.239892e-01 | 0.084 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.239892e-01 | 0.084 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.239892e-01 | 0.084 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 8.239892e-01 | 0.084 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.239892e-01 | 0.084 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.239892e-01 | 0.084 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.239892e-01 | 0.084 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 8.261596e-01 | 0.083 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.261596e-01 | 0.083 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.272549e-01 | 0.082 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 8.289725e-01 | 0.081 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.297755e-01 | 0.081 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.297755e-01 | 0.081 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.297755e-01 | 0.081 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.313465e-01 | 0.080 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 8.313465e-01 | 0.080 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.313465e-01 | 0.080 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.313465e-01 | 0.080 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.313465e-01 | 0.080 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.313465e-01 | 0.080 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 8.321862e-01 | 0.080 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.344165e-01 | 0.079 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.345952e-01 | 0.079 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.345952e-01 | 0.079 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.350101e-01 | 0.078 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.355025e-01 | 0.078 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.360266e-01 | 0.078 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 8.378904e-01 | 0.077 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.378904e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.411972e-01 | 0.075 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.425666e-01 | 0.074 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.454885e-01 | 0.073 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.454885e-01 | 0.073 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.454885e-01 | 0.073 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.460149e-01 | 0.073 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.460149e-01 | 0.073 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.460149e-01 | 0.073 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.460149e-01 | 0.073 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.460149e-01 | 0.073 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.460149e-01 | 0.073 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.460149e-01 | 0.073 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 8.460149e-01 | 0.073 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.460149e-01 | 0.073 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.463524e-01 | 0.072 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.463524e-01 | 0.072 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.463524e-01 | 0.072 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.488112e-01 | 0.071 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.501480e-01 | 0.071 | 0 | 0 |
| Depurination | R-HSA-73927 | 8.501480e-01 | 0.071 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.534398e-01 | 0.069 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.544334e-01 | 0.068 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.545702e-01 | 0.068 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.545702e-01 | 0.068 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.568069e-01 | 0.067 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.592249e-01 | 0.066 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.593981e-01 | 0.066 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.614475e-01 | 0.065 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.614475e-01 | 0.065 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.614475e-01 | 0.065 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 8.630118e-01 | 0.064 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.652855e-01 | 0.063 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.652855e-01 | 0.063 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.652855e-01 | 0.063 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.652855e-01 | 0.063 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.652855e-01 | 0.063 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.652855e-01 | 0.063 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.652855e-01 | 0.063 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.652855e-01 | 0.063 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.652855e-01 | 0.063 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.662227e-01 | 0.062 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.662227e-01 | 0.062 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.669442e-01 | 0.062 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.669442e-01 | 0.062 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.669442e-01 | 0.062 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.707044e-01 | 0.060 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.711429e-01 | 0.060 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 8.714912e-01 | 0.060 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.723151e-01 | 0.059 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 8.723151e-01 | 0.059 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.723151e-01 | 0.059 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.723151e-01 | 0.059 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.731937e-01 | 0.059 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 8.751721e-01 | 0.058 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 8.751721e-01 | 0.058 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 8.751721e-01 | 0.058 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.753774e-01 | 0.058 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.764693e-01 | 0.057 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.764693e-01 | 0.057 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.777895e-01 | 0.057 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.794503e-01 | 0.056 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.797310e-01 | 0.056 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.816516e-01 | 0.055 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.817982e-01 | 0.055 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.821454e-01 | 0.054 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.821454e-01 | 0.054 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.821454e-01 | 0.054 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.821454e-01 | 0.054 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.821454e-01 | 0.054 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.821454e-01 | 0.054 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.821454e-01 | 0.054 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.821454e-01 | 0.054 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.821454e-01 | 0.054 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 8.821454e-01 | 0.054 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.822968e-01 | 0.054 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.822968e-01 | 0.054 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.834353e-01 | 0.054 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.844182e-01 | 0.053 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.859037e-01 | 0.053 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 8.868899e-01 | 0.052 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.876326e-01 | 0.052 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.876326e-01 | 0.052 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 8.876326e-01 | 0.052 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.876326e-01 | 0.052 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 8.897787e-01 | 0.051 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.897787e-01 | 0.051 | 1 | 1 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.915924e-01 | 0.050 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.915924e-01 | 0.050 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.915924e-01 | 0.050 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.915924e-01 | 0.050 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.915924e-01 | 0.050 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.924873e-01 | 0.049 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.932330e-01 | 0.049 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.937857e-01 | 0.049 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.937857e-01 | 0.049 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.968962e-01 | 0.047 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.968962e-01 | 0.047 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.968962e-01 | 0.047 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.968962e-01 | 0.047 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.968962e-01 | 0.047 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.968962e-01 | 0.047 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.968962e-01 | 0.047 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.968962e-01 | 0.047 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.968962e-01 | 0.047 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.973557e-01 | 0.047 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.989304e-01 | 0.046 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.989304e-01 | 0.046 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.989304e-01 | 0.046 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.989304e-01 | 0.046 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.998538e-01 | 0.046 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 8.998538e-01 | 0.046 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.002380e-01 | 0.046 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.002380e-01 | 0.046 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 9.015947e-01 | 0.045 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 9.015947e-01 | 0.045 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.016290e-01 | 0.045 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.017111e-01 | 0.045 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.017111e-01 | 0.045 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.017111e-01 | 0.045 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.017111e-01 | 0.045 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.025279e-01 | 0.045 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.044822e-01 | 0.044 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.044822e-01 | 0.044 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.048531e-01 | 0.043 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.070057e-01 | 0.042 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.082690e-01 | 0.042 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.082690e-01 | 0.042 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.089633e-01 | 0.041 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.091613e-01 | 0.041 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 9.091613e-01 | 0.041 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.091613e-01 | 0.041 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.091613e-01 | 0.041 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.098014e-01 | 0.041 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.098014e-01 | 0.041 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.098014e-01 | 0.041 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.098014e-01 | 0.041 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.098014e-01 | 0.041 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.098014e-01 | 0.041 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.098014e-01 | 0.041 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.098014e-01 | 0.041 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 9.098014e-01 | 0.041 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.100385e-01 | 0.041 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.104492e-01 | 0.041 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.104492e-01 | 0.041 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.104492e-01 | 0.041 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.104492e-01 | 0.041 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.107342e-01 | 0.041 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.107342e-01 | 0.041 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.141968e-01 | 0.039 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.153002e-01 | 0.038 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.153002e-01 | 0.038 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.153002e-01 | 0.038 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.184154e-01 | 0.037 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.184154e-01 | 0.037 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.184154e-01 | 0.037 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.184154e-01 | 0.037 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.184154e-01 | 0.037 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.184154e-01 | 0.037 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.184757e-01 | 0.037 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.184757e-01 | 0.037 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.195853e-01 | 0.036 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.206742e-01 | 0.036 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.210920e-01 | 0.036 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 9.210920e-01 | 0.036 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.210920e-01 | 0.036 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.210920e-01 | 0.036 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.210920e-01 | 0.036 | 0 | 0 |
| Events associated with phagocytolytic activity of PMN cells | R-HSA-8941413 | 9.210920e-01 | 0.036 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.210920e-01 | 0.036 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.210920e-01 | 0.036 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 9.210920e-01 | 0.036 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.212575e-01 | 0.036 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.212575e-01 | 0.036 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.222065e-01 | 0.035 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 9.229712e-01 | 0.035 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.250564e-01 | 0.034 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.254066e-01 | 0.034 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.254066e-01 | 0.034 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.258401e-01 | 0.033 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.262080e-01 | 0.033 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.267768e-01 | 0.033 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.267768e-01 | 0.033 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 9.267768e-01 | 0.033 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.267768e-01 | 0.033 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.267768e-01 | 0.033 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.267768e-01 | 0.033 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.281650e-01 | 0.032 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.282793e-01 | 0.032 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.290188e-01 | 0.032 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.290188e-01 | 0.032 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.290188e-01 | 0.032 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.309699e-01 | 0.031 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.309699e-01 | 0.031 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.309699e-01 | 0.031 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.309699e-01 | 0.031 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.309699e-01 | 0.031 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.309699e-01 | 0.031 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.309699e-01 | 0.031 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.309699e-01 | 0.031 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.322949e-01 | 0.030 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.325892e-01 | 0.030 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 9.325892e-01 | 0.030 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.331598e-01 | 0.030 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.340579e-01 | 0.030 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.343239e-01 | 0.030 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.343239e-01 | 0.030 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.349307e-01 | 0.029 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.349307e-01 | 0.029 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.371394e-01 | 0.028 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.388753e-01 | 0.027 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.396117e-01 | 0.027 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.396117e-01 | 0.027 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.396117e-01 | 0.027 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.396117e-01 | 0.027 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.396117e-01 | 0.027 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.396117e-01 | 0.027 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.398505e-01 | 0.027 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.398526e-01 | 0.027 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.398526e-01 | 0.027 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.403922e-01 | 0.027 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.411296e-01 | 0.026 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.411296e-01 | 0.026 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.436727e-01 | 0.025 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.444190e-01 | 0.025 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.454328e-01 | 0.024 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.456778e-01 | 0.024 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.471721e-01 | 0.024 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.471721e-01 | 0.024 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.471721e-01 | 0.024 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.471721e-01 | 0.024 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.475989e-01 | 0.023 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.497618e-01 | 0.022 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.497618e-01 | 0.022 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.511203e-01 | 0.022 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.512416e-01 | 0.022 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.524480e-01 | 0.021 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.527806e-01 | 0.021 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.527806e-01 | 0.021 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.537864e-01 | 0.021 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.537864e-01 | 0.021 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 9.537864e-01 | 0.021 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.537864e-01 | 0.021 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.537864e-01 | 0.021 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.537864e-01 | 0.021 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.537864e-01 | 0.021 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.537864e-01 | 0.021 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.537864e-01 | 0.021 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.539114e-01 | 0.020 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.542950e-01 | 0.020 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.543619e-01 | 0.020 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.557141e-01 | 0.020 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.560910e-01 | 0.020 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.568441e-01 | 0.019 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.568441e-01 | 0.019 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.568441e-01 | 0.019 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.577451e-01 | 0.019 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.584004e-01 | 0.018 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.587780e-01 | 0.018 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.595728e-01 | 0.018 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.595728e-01 | 0.018 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 9.595728e-01 | 0.018 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.595728e-01 | 0.018 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 9.595728e-01 | 0.018 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.595728e-01 | 0.018 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.610799e-01 | 0.017 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.611560e-01 | 0.017 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.617985e-01 | 0.017 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.622611e-01 | 0.017 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.625099e-01 | 0.017 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.625099e-01 | 0.017 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.625099e-01 | 0.017 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.638445e-01 | 0.016 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.646351e-01 | 0.016 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.646351e-01 | 0.016 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.646351e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.646351e-01 | 0.016 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.646351e-01 | 0.016 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 9.646351e-01 | 0.016 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 9.646351e-01 | 0.016 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.652557e-01 | 0.015 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.652557e-01 | 0.015 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.659586e-01 | 0.015 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.660759e-01 | 0.015 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.662146e-01 | 0.015 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.662146e-01 | 0.015 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.668312e-01 | 0.015 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.690637e-01 | 0.014 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.690637e-01 | 0.014 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.690637e-01 | 0.014 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.690637e-01 | 0.014 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.690637e-01 | 0.014 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.690637e-01 | 0.014 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.690637e-01 | 0.014 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.690637e-01 | 0.014 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.690637e-01 | 0.014 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.698113e-01 | 0.013 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.698113e-01 | 0.013 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.700008e-01 | 0.013 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.712783e-01 | 0.013 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.713928e-01 | 0.013 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.722690e-01 | 0.012 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.723599e-01 | 0.012 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.729379e-01 | 0.012 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.729379e-01 | 0.012 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.729379e-01 | 0.012 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.730373e-01 | 0.012 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.730373e-01 | 0.012 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.745468e-01 | 0.011 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.759290e-01 | 0.011 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.759290e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.759290e-01 | 0.011 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.763272e-01 | 0.010 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.763272e-01 | 0.010 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.763272e-01 | 0.010 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.763272e-01 | 0.010 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.763272e-01 | 0.010 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.781982e-01 | 0.010 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.785196e-01 | 0.009 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.785196e-01 | 0.009 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.785196e-01 | 0.009 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.792922e-01 | 0.009 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 9.792922e-01 | 0.009 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.792922e-01 | 0.009 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.792922e-01 | 0.009 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.792922e-01 | 0.009 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.792922e-01 | 0.009 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.808390e-01 | 0.008 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.808390e-01 | 0.008 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.808390e-01 | 0.008 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.808390e-01 | 0.008 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.818859e-01 | 0.008 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.818859e-01 | 0.008 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.818859e-01 | 0.008 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.818859e-01 | 0.008 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.819726e-01 | 0.008 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.829145e-01 | 0.007 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.841549e-01 | 0.007 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.841549e-01 | 0.007 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.841549e-01 | 0.007 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.841549e-01 | 0.007 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.841549e-01 | 0.007 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.841549e-01 | 0.007 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.843016e-01 | 0.007 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.845985e-01 | 0.007 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.847709e-01 | 0.007 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.847709e-01 | 0.007 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.847709e-01 | 0.007 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.850371e-01 | 0.007 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.850391e-01 | 0.007 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.859033e-01 | 0.006 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.859328e-01 | 0.006 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.861398e-01 | 0.006 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.861398e-01 | 0.006 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.863164e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.864305e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.864305e-01 | 0.006 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.864305e-01 | 0.006 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.864305e-01 | 0.006 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.864305e-01 | 0.006 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.865213e-01 | 0.006 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.865213e-01 | 0.006 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.878762e-01 | 0.005 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.878762e-01 | 0.005 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.878762e-01 | 0.005 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.878762e-01 | 0.005 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.878762e-01 | 0.005 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.878762e-01 | 0.005 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.878762e-01 | 0.005 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.879133e-01 | 0.005 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.879133e-01 | 0.005 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.881432e-01 | 0.005 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.891978e-01 | 0.005 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.892378e-01 | 0.005 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.893104e-01 | 0.005 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.893951e-01 | 0.005 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.893951e-01 | 0.005 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.893951e-01 | 0.005 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.895646e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.899235e-01 | 0.004 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.899333e-01 | 0.004 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.901725e-01 | 0.004 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.901725e-01 | 0.004 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 9.904201e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.904201e-01 | 0.004 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.907238e-01 | 0.004 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.907238e-01 | 0.004 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.907238e-01 | 0.004 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.907238e-01 | 0.004 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.907238e-01 | 0.004 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.914753e-01 | 0.004 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.915510e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.916492e-01 | 0.004 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.918037e-01 | 0.004 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.918861e-01 | 0.004 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.918861e-01 | 0.004 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.924164e-01 | 0.003 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.924164e-01 | 0.003 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.924164e-01 | 0.003 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.924164e-01 | 0.003 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.925107e-01 | 0.003 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.927603e-01 | 0.003 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.929028e-01 | 0.003 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.929028e-01 | 0.003 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.929028e-01 | 0.003 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.929028e-01 | 0.003 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.930169e-01 | 0.003 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.930169e-01 | 0.003 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.930620e-01 | 0.003 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.932557e-01 | 0.003 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.932557e-01 | 0.003 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.935863e-01 | 0.003 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.936008e-01 | 0.003 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.937922e-01 | 0.003 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.942407e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.942407e-01 | 0.003 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.944982e-01 | 0.002 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.945605e-01 | 0.002 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.945702e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.946703e-01 | 0.002 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.948857e-01 | 0.002 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.950146e-01 | 0.002 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.953347e-01 | 0.002 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.953607e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.954146e-01 | 0.002 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.954684e-01 | 0.002 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.954684e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.958389e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.958459e-01 | 0.002 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.958459e-01 | 0.002 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.958459e-01 | 0.002 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.958459e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.958459e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.958459e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.961657e-01 | 0.002 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.963666e-01 | 0.002 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.963666e-01 | 0.002 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.963666e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.963666e-01 | 0.002 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.965655e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.966624e-01 | 0.001 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.966624e-01 | 0.001 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.968221e-01 | 0.001 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.968221e-01 | 0.001 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.970346e-01 | 0.001 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.972204e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.972204e-01 | 0.001 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.972204e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.973135e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.973135e-01 | 0.001 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.973718e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.975937e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.977864e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.978737e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.978737e-01 | 0.001 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.980713e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.980713e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.980910e-01 | 0.001 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 9.981403e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.981403e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.982228e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.982740e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.982740e-01 | 0.001 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.982891e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.983735e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.983735e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.983813e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.983813e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.984557e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.984871e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.985774e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.985774e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.985829e-01 | 0.001 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.987199e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.988400e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.988400e-01 | 0.001 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.988683e-01 | 0.000 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.989118e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.990010e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990010e-01 | 0.000 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 9.990131e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.990483e-01 | 0.000 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.990896e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.991677e-01 | 0.000 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.992122e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.992122e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.992721e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.993002e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.993312e-01 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.993634e-01 | 0.000 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.993962e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.994392e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.994432e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.995131e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.995735e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.996093e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.996247e-01 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.996276e-01 | 0.000 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.996276e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.996590e-01 | 0.000 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.996743e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.997046e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.997046e-01 | 0.000 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.997152e-01 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.997152e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.997591e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.997752e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.998095e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.998095e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998522e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998641e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998651e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998651e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.998726e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.998726e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.998741e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.998886e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.998886e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998897e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.999004e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.999026e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999139e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999255e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999255e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999349e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999349e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999430e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999565e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999632e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999639e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999709e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999777e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999805e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999805e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999838e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999862e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999881e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999883e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999894e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999901e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999906e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999909e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999911e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999934e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999949e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999956e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999963e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999967e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999970e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999971e-01 | 0.000 | 1 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999973e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999977e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999982e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999986e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999990e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999990e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999993e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999994e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999996e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999998e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999999e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.289968e-12 | 11.889 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.012535e-11 | 10.995 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.163281e-11 | 10.500 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 9.960321e-11 | 10.002 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.316043e-10 | 9.881 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.283513e-10 | 9.202 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.664506e-09 | 8.779 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.723656e-09 | 8.242 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.242877e-08 | 7.906 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.320192e-08 | 7.879 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.500090e-08 | 7.824 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.922870e-08 | 7.716 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.877351e-08 | 7.726 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.307984e-08 | 7.366 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.307984e-08 | 7.366 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 5.076010e-08 | 7.294 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 5.334728e-08 | 7.273 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.482196e-07 | 6.829 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.451285e-07 | 6.838 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.801453e-07 | 6.744 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.033330e-07 | 6.518 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.601500e-07 | 6.337 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.601500e-07 | 6.337 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.168024e-07 | 6.380 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.343123e-07 | 6.362 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 5.907674e-07 | 6.229 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.095727e-07 | 6.149 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.997232e-07 | 6.097 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.394353e-07 | 6.076 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.020138e-06 | 5.991 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.020138e-06 | 5.991 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 1.047140e-06 | 5.980 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 1.047140e-06 | 5.980 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 9.590331e-07 | 6.018 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.074690e-06 | 5.969 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.582000e-06 | 5.801 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.675695e-06 | 5.776 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.675695e-06 | 5.776 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.764759e-06 | 5.753 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.784188e-06 | 5.749 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.814500e-06 | 5.741 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.825320e-06 | 5.739 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.214221e-06 | 5.655 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.474545e-06 | 5.607 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.862209e-06 | 5.543 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.901913e-06 | 5.537 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.149153e-06 | 5.502 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.418811e-06 | 5.466 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 4.010452e-06 | 5.397 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 4.104853e-06 | 5.387 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.270643e-06 | 5.370 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.512025e-06 | 5.346 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.328748e-06 | 5.273 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.606712e-06 | 5.251 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.951354e-06 | 5.225 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.266359e-06 | 5.203 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.285905e-06 | 5.202 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.717022e-06 | 5.060 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.824449e-06 | 5.054 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.053439e-05 | 4.977 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.167827e-05 | 4.933 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.280821e-05 | 4.893 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.412423e-05 | 4.850 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.509935e-05 | 4.821 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.551754e-05 | 4.809 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.575055e-05 | 4.803 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.752343e-05 | 4.756 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.755630e-05 | 4.756 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 2.052235e-05 | 4.688 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.226581e-05 | 4.652 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.464107e-05 | 4.608 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.399238e-05 | 4.620 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.375519e-05 | 4.624 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.573933e-05 | 4.589 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.742937e-05 | 4.562 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.990525e-05 | 4.524 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 4.019240e-05 | 4.396 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 4.323444e-05 | 4.364 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.235624e-05 | 4.373 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.634547e-05 | 4.334 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 5.027532e-05 | 4.299 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 5.587627e-05 | 4.253 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 5.846040e-05 | 4.233 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.658600e-05 | 4.177 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 6.731450e-05 | 4.172 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.735352e-05 | 4.112 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.766967e-05 | 4.110 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 8.638311e-05 | 4.064 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 9.506157e-05 | 4.022 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.895057e-05 | 4.005 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.075850e-04 | 3.968 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.123561e-04 | 3.949 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.215958e-04 | 3.915 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.225089e-04 | 3.912 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.316675e-04 | 3.881 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.548970e-04 | 3.810 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.611175e-04 | 3.793 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.658134e-04 | 3.780 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.665082e-04 | 3.779 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.900830e-04 | 3.721 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.998866e-04 | 3.699 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.071439e-04 | 3.684 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.084798e-04 | 3.681 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.317944e-04 | 3.635 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.474278e-04 | 3.607 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.497690e-04 | 3.602 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.062622e-04 | 3.514 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.159103e-04 | 3.500 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.392192e-04 | 3.470 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.392192e-04 | 3.470 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.392192e-04 | 3.470 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.392192e-04 | 3.470 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.527621e-04 | 3.453 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.527621e-04 | 3.453 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 3.511459e-04 | 3.455 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.341796e-04 | 3.476 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 4.085554e-04 | 3.389 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 4.286739e-04 | 3.368 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.425512e-04 | 3.354 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 4.472780e-04 | 3.349 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 4.955511e-04 | 3.305 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.653337e-04 | 3.332 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 4.720144e-04 | 3.326 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.370070e-04 | 3.270 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.985898e-04 | 3.223 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.187778e-04 | 3.208 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.401628e-04 | 3.194 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.674749e-04 | 3.176 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.729303e-04 | 3.172 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 7.323218e-04 | 3.135 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 7.865764e-04 | 3.104 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.264984e-04 | 3.083 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.234965e-04 | 3.084 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.504295e-04 | 3.070 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 8.725839e-04 | 3.059 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.238046e-04 | 3.034 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.516101e-04 | 3.022 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 9.637868e-04 | 3.016 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.144256e-03 | 2.941 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.155177e-03 | 2.937 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.277135e-03 | 2.894 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.310951e-03 | 2.882 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.338268e-03 | 2.873 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.484201e-03 | 2.829 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.484201e-03 | 2.829 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.484201e-03 | 2.829 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.497559e-03 | 2.825 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.526194e-03 | 2.816 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.605574e-03 | 2.794 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.783509e-03 | 2.749 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.791215e-03 | 2.747 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.866249e-03 | 2.729 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.918027e-03 | 2.717 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.918027e-03 | 2.717 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.035151e-03 | 2.691 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.093090e-03 | 2.679 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.277764e-03 | 2.642 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.624421e-03 | 2.581 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.823027e-03 | 2.549 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 2.823027e-03 | 2.549 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.831253e-03 | 2.548 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.861568e-03 | 2.543 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.897398e-03 | 2.538 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.905585e-03 | 2.537 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.905585e-03 | 2.537 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.990937e-03 | 2.524 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 2.990937e-03 | 2.524 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.069430e-03 | 2.513 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.428879e-03 | 2.465 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.516094e-03 | 2.454 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.620184e-03 | 2.441 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.712411e-03 | 2.430 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.712411e-03 | 2.430 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.692344e-03 | 2.433 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.660335e-03 | 2.436 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.113167e-03 | 2.386 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.113167e-03 | 2.386 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.562245e-03 | 2.341 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.671723e-03 | 2.331 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.886133e-03 | 2.311 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.084453e-03 | 2.294 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.099428e-03 | 2.292 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.099428e-03 | 2.292 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.099428e-03 | 2.292 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.317130e-03 | 2.274 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.805981e-03 | 2.236 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.891886e-03 | 2.230 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.896985e-03 | 2.229 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.008608e-03 | 2.221 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.199694e-03 | 2.143 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.199694e-03 | 2.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.199694e-03 | 2.143 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.199694e-03 | 2.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.199694e-03 | 2.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.199694e-03 | 2.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.199694e-03 | 2.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.199694e-03 | 2.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.199694e-03 | 2.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.199694e-03 | 2.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.199694e-03 | 2.143 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.525519e-03 | 2.123 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.993704e-03 | 2.155 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.232544e-03 | 2.141 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.543805e-03 | 2.122 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 7.785946e-03 | 2.109 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 7.926182e-03 | 2.101 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.040272e-03 | 2.095 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.100598e-03 | 2.091 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.803167e-03 | 2.055 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 8.813461e-03 | 2.055 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 9.413212e-03 | 2.026 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 9.671348e-03 | 2.015 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.024469e-02 | 1.990 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.067817e-02 | 1.972 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.106857e-02 | 1.956 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.125916e-02 | 1.948 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.133715e-02 | 1.945 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.168304e-02 | 1.932 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.168304e-02 | 1.932 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.186991e-02 | 1.926 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.186991e-02 | 1.926 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.186991e-02 | 1.926 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.186991e-02 | 1.926 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 1.268376e-02 | 1.897 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.280569e-02 | 1.893 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.296570e-02 | 1.887 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.310238e-02 | 1.883 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.506220e-02 | 1.822 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.529635e-02 | 1.815 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.529635e-02 | 1.815 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.414875e-02 | 1.849 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.411779e-02 | 1.850 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.420888e-02 | 1.847 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.420888e-02 | 1.847 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.365757e-02 | 1.865 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.543890e-02 | 1.811 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.564627e-02 | 1.806 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.565292e-02 | 1.805 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.565292e-02 | 1.805 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 1.601770e-02 | 1.795 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.640599e-02 | 1.785 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.731165e-02 | 1.762 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.731165e-02 | 1.762 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.731165e-02 | 1.762 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.741573e-02 | 1.759 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.741573e-02 | 1.759 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.748438e-02 | 1.757 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.751818e-02 | 1.757 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.753755e-02 | 1.756 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.761985e-02 | 1.754 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.784754e-02 | 1.748 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.811401e-02 | 1.742 | 0 | 0 |
| Translation | R-HSA-72766 | 1.857589e-02 | 1.731 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.958758e-02 | 1.708 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.969776e-02 | 1.706 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.002651e-02 | 1.698 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 2.007410e-02 | 1.697 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.024834e-02 | 1.694 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.025786e-02 | 1.693 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.094207e-02 | 1.679 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.140066e-02 | 1.670 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.204560e-02 | 1.657 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.582619e-02 | 1.588 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.290855e-02 | 1.640 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.597591e-02 | 1.585 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 2.313236e-02 | 1.636 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.581624e-02 | 1.588 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.607528e-02 | 1.584 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.250525e-02 | 1.648 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.607528e-02 | 1.584 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.430998e-02 | 1.614 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.639871e-02 | 1.578 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.299733e-02 | 1.638 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.681819e-02 | 1.572 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.421588e-02 | 1.616 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.307954e-02 | 1.637 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.421588e-02 | 1.616 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.826844e-02 | 1.549 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.831761e-02 | 1.548 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.884858e-02 | 1.540 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.937799e-02 | 1.532 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.953942e-02 | 1.530 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.966744e-02 | 1.528 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.993518e-02 | 1.524 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.069425e-02 | 1.513 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.124892e-02 | 1.505 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 3.124892e-02 | 1.505 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.146116e-02 | 1.502 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.175441e-02 | 1.498 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 3.202082e-02 | 1.495 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.237466e-02 | 1.490 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.321797e-02 | 1.479 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.331291e-02 | 1.477 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.366165e-02 | 1.473 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.424181e-02 | 1.465 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.463329e-02 | 1.461 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.466005e-02 | 1.460 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.605760e-02 | 1.443 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 3.669232e-02 | 1.435 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 3.669232e-02 | 1.435 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 3.733547e-02 | 1.428 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.796389e-02 | 1.421 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.809827e-02 | 1.419 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.821538e-02 | 1.418 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.821538e-02 | 1.418 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.870426e-02 | 1.412 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.870426e-02 | 1.412 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.870426e-02 | 1.412 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.887639e-02 | 1.410 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 3.887639e-02 | 1.410 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.002160e-02 | 1.398 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 4.351215e-02 | 1.361 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.351215e-02 | 1.361 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.656092e-02 | 1.332 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 4.364040e-02 | 1.360 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 4.364248e-02 | 1.360 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.920869e-02 | 1.308 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.183107e-02 | 1.379 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.851781e-02 | 1.314 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.070290e-02 | 1.295 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 4.177002e-02 | 1.379 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.016552e-02 | 1.300 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 4.183107e-02 | 1.379 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.498800e-02 | 1.347 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.849878e-02 | 1.314 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.686159e-02 | 1.329 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.364248e-02 | 1.360 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.177313e-02 | 1.379 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.714454e-02 | 1.327 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.089326e-02 | 1.388 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.695422e-02 | 1.328 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 4.942557e-02 | 1.306 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.102894e-02 | 1.292 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.212888e-02 | 1.283 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.373888e-02 | 1.270 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.477897e-02 | 1.261 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.508445e-02 | 1.259 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.611242e-02 | 1.251 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.621740e-02 | 1.250 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.688000e-02 | 1.245 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 5.688000e-02 | 1.245 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.688000e-02 | 1.245 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.781455e-02 | 1.238 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.905279e-02 | 1.229 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 5.925852e-02 | 1.227 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 6.047274e-02 | 1.218 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.221123e-02 | 1.206 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.326766e-02 | 1.199 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.326766e-02 | 1.199 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.338006e-02 | 1.198 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.444897e-02 | 1.191 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.708553e-02 | 1.173 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.918275e-02 | 1.160 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 6.918275e-02 | 1.160 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.083150e-02 | 1.150 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.083150e-02 | 1.150 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.132905e-02 | 1.147 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 7.313634e-02 | 1.136 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.370565e-02 | 1.132 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 7.370565e-02 | 1.132 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 7.370565e-02 | 1.132 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 7.403729e-02 | 1.131 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 7.403729e-02 | 1.131 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.403729e-02 | 1.131 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.525257e-02 | 1.123 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.589917e-02 | 1.120 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 7.890982e-02 | 1.103 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.903906e-02 | 1.102 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.967082e-02 | 1.099 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 8.159717e-02 | 1.088 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 8.264026e-02 | 1.083 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.455112e-02 | 1.073 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.455112e-02 | 1.073 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.455112e-02 | 1.073 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.582400e-02 | 1.066 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.648534e-02 | 1.063 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.205262e-02 | 1.036 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.151388e-01 | 0.939 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.151388e-01 | 0.939 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.151388e-01 | 0.939 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 9.203304e-02 | 1.036 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 9.203304e-02 | 1.036 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 9.203304e-02 | 1.036 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.116352e-01 | 0.952 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.116352e-01 | 0.952 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 8.750083e-02 | 1.058 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 1.148994e-01 | 0.940 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.994926e-02 | 1.046 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.140109e-01 | 0.943 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.153292e-01 | 0.938 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.116352e-01 | 0.952 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.142429e-01 | 0.942 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.065709e-01 | 0.972 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.749502e-02 | 1.011 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.056283e-01 | 0.976 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 1.050114e-01 | 0.979 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.116352e-01 | 0.952 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 1.065709e-01 | 0.972 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.065709e-01 | 0.972 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.979943e-02 | 1.047 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 9.203304e-02 | 1.036 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.116352e-01 | 0.952 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.116352e-01 | 0.952 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.069975e-01 | 0.971 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 8.939271e-02 | 1.049 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 9.646680e-02 | 1.016 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.116352e-01 | 0.952 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.660013e-02 | 1.015 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 9.782264e-02 | 1.010 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.022906e-01 | 0.990 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 8.750083e-02 | 1.058 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.116352e-01 | 0.952 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.055730e-01 | 0.976 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.142429e-01 | 0.942 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.036844e-01 | 0.984 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.230671e-02 | 1.035 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 1.036844e-01 | 0.984 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.124473e-01 | 0.949 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 1.100959e-01 | 0.958 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.038613e-01 | 0.984 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.406839e-02 | 1.027 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.161150e-01 | 0.935 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.162932e-01 | 0.934 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.195751e-01 | 0.922 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.234418e-01 | 0.909 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.234418e-01 | 0.909 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 1.266972e-01 | 0.897 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.268658e-01 | 0.897 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.279398e-01 | 0.893 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.279398e-01 | 0.893 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.279398e-01 | 0.893 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.279398e-01 | 0.893 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.279398e-01 | 0.893 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.281150e-01 | 0.892 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.305849e-01 | 0.884 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.305849e-01 | 0.884 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.305849e-01 | 0.884 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.305849e-01 | 0.884 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.305849e-01 | 0.884 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 1.317225e-01 | 0.880 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.318376e-01 | 0.880 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.318376e-01 | 0.880 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.326656e-01 | 0.877 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.326656e-01 | 0.877 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.326656e-01 | 0.877 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.338207e-01 | 0.873 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.390561e-01 | 0.857 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.390561e-01 | 0.857 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.400149e-01 | 0.854 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.412680e-01 | 0.850 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.756365e-01 | 0.755 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.756365e-01 | 0.755 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.756365e-01 | 0.755 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.756365e-01 | 0.755 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.756365e-01 | 0.755 | 0 | 0 |
| Defective GALM causes GALAC4 | R-HSA-9931929 | 1.756365e-01 | 0.755 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.756365e-01 | 0.755 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.756365e-01 | 0.755 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.756365e-01 | 0.755 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.756365e-01 | 0.755 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.756365e-01 | 0.755 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.756365e-01 | 0.755 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.474691e-01 | 0.831 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.474691e-01 | 0.831 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.474691e-01 | 0.831 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.813479e-01 | 0.741 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.813479e-01 | 0.741 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 1.813479e-01 | 0.741 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.813479e-01 | 0.741 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.162166e-01 | 0.665 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.162166e-01 | 0.665 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.162166e-01 | 0.665 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.549403e-01 | 0.810 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.549403e-01 | 0.810 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.549403e-01 | 0.810 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.549403e-01 | 0.810 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.549403e-01 | 0.810 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.782746e-01 | 0.749 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.024870e-01 | 0.694 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.024870e-01 | 0.694 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.024870e-01 | 0.694 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.024870e-01 | 0.694 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.024870e-01 | 0.694 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.658879e-01 | 0.780 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.658879e-01 | 0.780 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.658879e-01 | 0.780 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.846852e-01 | 0.734 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.846852e-01 | 0.734 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.041326e-01 | 0.690 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.041326e-01 | 0.690 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.519514e-01 | 0.818 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 1.456431e-01 | 0.837 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.083204e-01 | 0.681 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.611203e-01 | 0.793 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.715220e-01 | 0.766 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 1.485213e-01 | 0.828 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 1.485213e-01 | 0.828 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.846852e-01 | 0.734 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 1.653558e-01 | 0.782 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 1.613146e-01 | 0.792 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 1.456431e-01 | 0.837 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.863738e-01 | 0.730 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.935725e-01 | 0.713 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.792399e-01 | 0.747 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.792399e-01 | 0.747 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.613146e-01 | 0.792 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.455274e-01 | 0.837 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.083204e-01 | 0.681 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 2.129078e-01 | 0.672 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.024870e-01 | 0.694 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.846852e-01 | 0.734 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.519514e-01 | 0.818 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 2.024870e-01 | 0.694 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.505650e-01 | 0.822 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.149777e-01 | 0.668 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.672861e-01 | 0.777 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.999416e-01 | 0.699 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.782746e-01 | 0.749 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.792399e-01 | 0.747 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.863738e-01 | 0.730 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.129078e-01 | 0.672 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.944702e-01 | 0.711 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.736485e-01 | 0.760 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.127508e-01 | 0.672 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.994682e-01 | 0.700 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.160191e-01 | 0.666 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 1.834900e-01 | 0.736 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.754220e-01 | 0.756 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.518808e-01 | 0.818 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.813479e-01 | 0.741 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.999416e-01 | 0.699 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.792399e-01 | 0.747 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.584378e-01 | 0.800 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 1.658879e-01 | 0.780 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.756365e-01 | 0.755 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 1.474691e-01 | 0.831 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.782746e-01 | 0.749 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.782746e-01 | 0.749 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.478266e-01 | 0.830 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.024870e-01 | 0.694 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.083204e-01 | 0.681 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.926702e-01 | 0.715 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.656724e-01 | 0.781 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.772249e-01 | 0.751 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.834900e-01 | 0.736 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.672861e-01 | 0.777 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.599080e-01 | 0.796 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.584870e-01 | 0.800 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.455274e-01 | 0.837 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.129078e-01 | 0.672 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.031215e-01 | 0.692 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.563811e-01 | 0.806 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.907120e-01 | 0.720 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.077980e-01 | 0.682 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.863738e-01 | 0.730 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.675661e-01 | 0.776 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.680802e-01 | 0.774 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.162166e-01 | 0.665 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.478266e-01 | 0.830 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.792399e-01 | 0.747 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.994682e-01 | 0.700 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.480933e-01 | 0.829 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.478266e-01 | 0.830 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.026026e-01 | 0.693 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 1.813479e-01 | 0.741 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.168699e-01 | 0.664 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.863738e-01 | 0.730 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 2.041326e-01 | 0.690 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.813479e-01 | 0.741 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.478266e-01 | 0.830 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.792399e-01 | 0.747 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.730498e-01 | 0.762 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 2.234496e-01 | 0.651 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.234496e-01 | 0.651 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.234496e-01 | 0.651 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.234496e-01 | 0.651 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.241435e-01 | 0.649 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.241435e-01 | 0.649 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.241435e-01 | 0.649 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.241435e-01 | 0.649 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 2.241435e-01 | 0.649 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.241435e-01 | 0.649 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.264064e-01 | 0.645 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.266680e-01 | 0.645 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.266680e-01 | 0.645 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 2.268708e-01 | 0.644 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.274015e-01 | 0.643 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 2.274015e-01 | 0.643 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.278878e-01 | 0.642 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.342227e-01 | 0.630 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.359397e-01 | 0.627 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 2.389246e-01 | 0.622 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.407233e-01 | 0.618 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.407233e-01 | 0.618 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.407233e-01 | 0.618 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.408048e-01 | 0.618 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.446314e-01 | 0.611 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.446314e-01 | 0.611 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.446314e-01 | 0.611 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.446314e-01 | 0.611 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.446314e-01 | 0.611 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.464331e-01 | 0.608 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.515303e-01 | 0.599 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 2.515303e-01 | 0.599 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.515303e-01 | 0.599 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.515303e-01 | 0.599 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 2.515303e-01 | 0.599 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 2.515303e-01 | 0.599 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.515303e-01 | 0.599 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.515303e-01 | 0.599 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.516062e-01 | 0.599 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.516062e-01 | 0.599 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.516062e-01 | 0.599 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.516062e-01 | 0.599 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.516062e-01 | 0.599 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.516062e-01 | 0.599 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.516062e-01 | 0.599 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.516062e-01 | 0.599 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 2.519473e-01 | 0.599 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.520363e-01 | 0.599 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.520363e-01 | 0.599 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.528503e-01 | 0.597 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 2.528503e-01 | 0.597 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.528503e-01 | 0.597 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 2.547097e-01 | 0.594 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 2.547097e-01 | 0.594 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.547097e-01 | 0.594 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.550473e-01 | 0.593 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.592870e-01 | 0.586 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.204411e-01 | 0.494 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.204411e-01 | 0.494 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.204411e-01 | 0.494 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.830111e-01 | 0.417 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.830111e-01 | 0.417 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 3.830111e-01 | 0.417 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 3.830111e-01 | 0.417 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 3.830111e-01 | 0.417 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.830111e-01 | 0.417 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 2.871257e-01 | 0.542 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.871257e-01 | 0.542 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.871257e-01 | 0.542 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 2.871257e-01 | 0.542 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 2.871257e-01 | 0.542 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.224514e-01 | 0.492 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.224514e-01 | 0.492 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.224514e-01 | 0.492 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.398234e-01 | 0.357 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.398234e-01 | 0.357 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.398234e-01 | 0.357 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.398234e-01 | 0.357 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.786753e-01 | 0.555 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.786753e-01 | 0.555 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.573183e-01 | 0.447 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.573183e-01 | 0.447 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 3.573183e-01 | 0.447 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.573183e-01 | 0.447 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 3.308751e-01 | 0.480 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 3.308751e-01 | 0.480 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 3.915114e-01 | 0.407 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 3.915114e-01 | 0.407 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.914074e-01 | 0.309 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 4.914074e-01 | 0.309 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 4.914074e-01 | 0.309 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 4.914074e-01 | 0.309 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 4.914074e-01 | 0.309 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.296786e-01 | 0.482 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.296786e-01 | 0.482 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.248595e-01 | 0.372 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.248595e-01 | 0.372 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.829579e-01 | 0.417 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.513197e-01 | 0.454 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.443144e-01 | 0.463 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.729670e-01 | 0.428 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 4.086805e-01 | 0.389 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.572283e-01 | 0.340 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.572283e-01 | 0.340 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.572283e-01 | 0.340 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 3.945549e-01 | 0.404 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.945549e-01 | 0.404 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 3.945549e-01 | 0.404 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.158430e-01 | 0.501 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 4.160225e-01 | 0.381 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 4.885155e-01 | 0.311 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.605789e-01 | 0.443 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.590374e-01 | 0.338 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.216933e-01 | 0.375 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.835237e-01 | 0.316 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.186459e-01 | 0.285 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 4.791616e-01 | 0.320 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.074666e-01 | 0.295 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 3.465608e-01 | 0.460 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.255126e-01 | 0.487 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.829579e-01 | 0.417 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.035605e-01 | 0.518 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.035605e-01 | 0.518 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 4.226755e-01 | 0.374 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 2.707684e-01 | 0.567 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.583754e-01 | 0.339 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.785264e-01 | 0.422 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.785264e-01 | 0.422 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 3.047290e-01 | 0.516 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.248595e-01 | 0.372 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 4.583754e-01 | 0.339 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.385532e-01 | 0.358 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.373133e-01 | 0.359 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.513197e-01 | 0.454 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.248595e-01 | 0.372 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.035605e-01 | 0.518 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 3.573183e-01 | 0.447 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.296786e-01 | 0.482 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.114495e-01 | 0.291 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.785264e-01 | 0.422 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.573183e-01 | 0.447 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.573183e-01 | 0.447 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.047290e-01 | 0.516 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.248595e-01 | 0.372 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.226860e-01 | 0.491 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.983921e-01 | 0.525 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.753548e-01 | 0.323 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.605789e-01 | 0.443 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.047290e-01 | 0.516 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.086805e-01 | 0.389 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 2.871257e-01 | 0.542 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.786753e-01 | 0.555 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 4.914074e-01 | 0.309 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 4.248595e-01 | 0.372 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.572283e-01 | 0.340 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.047912e-01 | 0.297 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.729670e-01 | 0.428 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.202212e-01 | 0.495 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.594413e-01 | 0.444 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.248595e-01 | 0.372 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 4.572283e-01 | 0.340 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.945549e-01 | 0.404 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.871257e-01 | 0.542 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.841055e-01 | 0.315 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.835237e-01 | 0.316 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 4.340667e-01 | 0.362 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 2.871257e-01 | 0.542 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.398234e-01 | 0.357 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.573183e-01 | 0.447 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 4.914074e-01 | 0.309 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.202212e-01 | 0.495 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.443144e-01 | 0.463 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.186459e-01 | 0.285 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.699908e-01 | 0.569 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.708375e-01 | 0.327 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.605789e-01 | 0.443 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.729670e-01 | 0.428 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.883943e-01 | 0.411 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.138490e-01 | 0.503 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 4.398234e-01 | 0.357 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.915114e-01 | 0.407 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.914074e-01 | 0.309 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.047673e-01 | 0.393 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.186459e-01 | 0.285 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.333191e-01 | 0.363 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.953948e-01 | 0.403 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 3.308751e-01 | 0.480 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.708359e-01 | 0.431 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.900574e-01 | 0.310 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.970144e-01 | 0.527 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.051185e-01 | 0.297 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.333191e-01 | 0.363 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.083392e-01 | 0.294 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.725589e-01 | 0.565 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.204411e-01 | 0.494 | 0 | 0 |
| Adenosine P1 receptors | R-HSA-417973 | 3.830111e-01 | 0.417 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.830111e-01 | 0.417 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 3.047290e-01 | 0.516 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 3.915114e-01 | 0.407 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.914074e-01 | 0.309 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.914074e-01 | 0.309 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.160225e-01 | 0.381 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 4.885155e-01 | 0.311 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.373133e-01 | 0.359 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.047673e-01 | 0.393 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.385532e-01 | 0.358 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.255126e-01 | 0.487 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.913665e-01 | 0.536 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.727308e-01 | 0.325 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 3.654395e-01 | 0.437 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 2.870642e-01 | 0.542 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.767793e-01 | 0.322 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 3.224514e-01 | 0.492 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.914074e-01 | 0.309 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.197339e-01 | 0.377 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.768411e-01 | 0.424 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.144941e-01 | 0.502 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.144941e-01 | 0.502 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.009350e-01 | 0.397 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.224514e-01 | 0.492 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 2.786753e-01 | 0.555 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 2.866986e-01 | 0.543 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.914074e-01 | 0.309 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.707684e-01 | 0.567 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.572283e-01 | 0.340 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.451281e-01 | 0.462 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.451281e-01 | 0.462 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.497026e-01 | 0.456 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.618762e-01 | 0.441 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.224514e-01 | 0.492 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.891406e-01 | 0.539 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.068248e-01 | 0.513 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.074666e-01 | 0.295 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.569890e-01 | 0.447 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 3.830111e-01 | 0.417 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.398234e-01 | 0.357 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.573183e-01 | 0.447 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.047290e-01 | 0.516 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 4.914074e-01 | 0.309 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.914074e-01 | 0.309 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.248595e-01 | 0.372 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.068248e-01 | 0.513 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.829579e-01 | 0.417 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.035605e-01 | 0.518 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.820706e-01 | 0.418 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.590374e-01 | 0.338 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.798191e-01 | 0.420 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 5.186459e-01 | 0.285 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.114495e-01 | 0.291 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 4.991979e-01 | 0.302 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 3.605789e-01 | 0.443 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.340667e-01 | 0.362 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.573183e-01 | 0.447 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 5.186459e-01 | 0.285 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.802526e-01 | 0.319 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.829579e-01 | 0.417 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 2.871257e-01 | 0.542 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.224514e-01 | 0.492 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.398234e-01 | 0.357 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.398234e-01 | 0.357 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.573183e-01 | 0.447 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.914074e-01 | 0.309 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.914074e-01 | 0.309 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 4.914074e-01 | 0.309 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.248595e-01 | 0.372 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.829579e-01 | 0.417 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.009350e-01 | 0.397 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 4.197339e-01 | 0.377 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.690697e-01 | 0.433 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.569796e-01 | 0.340 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 3.035605e-01 | 0.518 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.553188e-01 | 0.342 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.513197e-01 | 0.454 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.081137e-01 | 0.511 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.035605e-01 | 0.518 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.572283e-01 | 0.340 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.572283e-01 | 0.340 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 2.804907e-01 | 0.552 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 3.081137e-01 | 0.511 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.216933e-01 | 0.375 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.224514e-01 | 0.492 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.786753e-01 | 0.555 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 2.786753e-01 | 0.555 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.248595e-01 | 0.372 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.443144e-01 | 0.463 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.631824e-01 | 0.440 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.702669e-01 | 0.568 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.141464e-01 | 0.289 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.943516e-01 | 0.306 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 4.791616e-01 | 0.320 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.047673e-01 | 0.393 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.047673e-01 | 0.393 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.885155e-01 | 0.311 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.835237e-01 | 0.316 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 4.569796e-01 | 0.340 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 4.835237e-01 | 0.316 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.062770e-01 | 0.514 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 5.186459e-01 | 0.285 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 4.935213e-01 | 0.307 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.573183e-01 | 0.447 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.086805e-01 | 0.389 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.885155e-01 | 0.311 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.885155e-01 | 0.311 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.569796e-01 | 0.340 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 5.186459e-01 | 0.285 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.197400e-01 | 0.284 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.216424e-01 | 0.283 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 5.234756e-01 | 0.281 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 5.291125e-01 | 0.276 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 5.299216e-01 | 0.276 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.308160e-01 | 0.275 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.308160e-01 | 0.275 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.308160e-01 | 0.275 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 5.368547e-01 | 0.270 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.382441e-01 | 0.269 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.382441e-01 | 0.269 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.382441e-01 | 0.269 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.382441e-01 | 0.269 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.382441e-01 | 0.269 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.382441e-01 | 0.269 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.382441e-01 | 0.269 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.382441e-01 | 0.269 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 5.382441e-01 | 0.269 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 5.382441e-01 | 0.269 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 5.382441e-01 | 0.269 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.382441e-01 | 0.269 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.382441e-01 | 0.269 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.382441e-01 | 0.269 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.382441e-01 | 0.269 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.382441e-01 | 0.269 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.382441e-01 | 0.269 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.382441e-01 | 0.269 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.382441e-01 | 0.269 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.382441e-01 | 0.269 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 5.435441e-01 | 0.265 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.464855e-01 | 0.262 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 5.475672e-01 | 0.262 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.475672e-01 | 0.262 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 5.475672e-01 | 0.262 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.475672e-01 | 0.262 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.475672e-01 | 0.262 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.475672e-01 | 0.262 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 5.475672e-01 | 0.262 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 5.535304e-01 | 0.257 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 5.548852e-01 | 0.256 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.548852e-01 | 0.256 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.551990e-01 | 0.256 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.579136e-01 | 0.253 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.579625e-01 | 0.253 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.587599e-01 | 0.253 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.587599e-01 | 0.253 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.587599e-01 | 0.253 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.630241e-01 | 0.249 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 5.635466e-01 | 0.249 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 5.652982e-01 | 0.248 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.679973e-01 | 0.246 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.679973e-01 | 0.246 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.746727e-01 | 0.241 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.752467e-01 | 0.240 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 5.752467e-01 | 0.240 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 5.752467e-01 | 0.240 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.755763e-01 | 0.240 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.755763e-01 | 0.240 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 5.776136e-01 | 0.238 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 5.776136e-01 | 0.238 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.776136e-01 | 0.238 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.802759e-01 | 0.236 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 5.802759e-01 | 0.236 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.802759e-01 | 0.236 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 5.802759e-01 | 0.236 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.802759e-01 | 0.236 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.804341e-01 | 0.236 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.807700e-01 | 0.236 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.807700e-01 | 0.236 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.807700e-01 | 0.236 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.807700e-01 | 0.236 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 5.807700e-01 | 0.236 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.807700e-01 | 0.236 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.807700e-01 | 0.236 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.807700e-01 | 0.236 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.807700e-01 | 0.236 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.807700e-01 | 0.236 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.807700e-01 | 0.236 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.807700e-01 | 0.236 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.807700e-01 | 0.236 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.807700e-01 | 0.236 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 5.834602e-01 | 0.234 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.959995e-01 | 0.225 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.959995e-01 | 0.225 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.966560e-01 | 0.224 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 5.969273e-01 | 0.224 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 5.969273e-01 | 0.224 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.969273e-01 | 0.224 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.999334e-01 | 0.222 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 6.016677e-01 | 0.221 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.016677e-01 | 0.221 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 6.016677e-01 | 0.221 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.016677e-01 | 0.221 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.016677e-01 | 0.221 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.042161e-01 | 0.219 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.088034e-01 | 0.216 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.115653e-01 | 0.214 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.175633e-01 | 0.209 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.175633e-01 | 0.209 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.175633e-01 | 0.209 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.175633e-01 | 0.209 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 6.193818e-01 | 0.208 | 0 | 0 |
| Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | R-HSA-964827 | 6.193818e-01 | 0.208 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 6.193818e-01 | 0.208 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.193818e-01 | 0.208 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.193818e-01 | 0.208 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.193818e-01 | 0.208 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.193818e-01 | 0.208 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.193818e-01 | 0.208 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 6.193818e-01 | 0.208 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 6.193818e-01 | 0.208 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.193818e-01 | 0.208 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.193818e-01 | 0.208 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.193818e-01 | 0.208 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.193818e-01 | 0.208 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 6.193818e-01 | 0.208 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.193818e-01 | 0.208 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.193818e-01 | 0.208 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.267303e-01 | 0.203 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.268272e-01 | 0.203 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.268272e-01 | 0.203 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.268272e-01 | 0.203 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.268272e-01 | 0.203 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.268272e-01 | 0.203 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.268272e-01 | 0.203 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.268272e-01 | 0.203 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.268272e-01 | 0.203 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 6.270190e-01 | 0.203 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.283099e-01 | 0.202 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.283099e-01 | 0.202 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.312979e-01 | 0.200 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.312979e-01 | 0.200 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.374705e-01 | 0.196 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.374705e-01 | 0.196 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.374705e-01 | 0.196 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 6.398321e-01 | 0.194 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 6.435596e-01 | 0.191 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.481838e-01 | 0.188 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.481838e-01 | 0.188 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 6.507335e-01 | 0.187 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.507335e-01 | 0.187 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.507335e-01 | 0.187 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.507335e-01 | 0.187 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 6.507335e-01 | 0.187 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 6.507335e-01 | 0.187 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.507335e-01 | 0.187 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 6.507335e-01 | 0.187 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.507335e-01 | 0.187 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.508603e-01 | 0.187 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.509107e-01 | 0.186 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 6.513834e-01 | 0.186 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.524939e-01 | 0.185 | 0 | 0 |
| RSK activation | R-HSA-444257 | 6.544395e-01 | 0.184 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.544395e-01 | 0.184 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.544395e-01 | 0.184 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.544395e-01 | 0.184 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.544395e-01 | 0.184 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.544395e-01 | 0.184 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.544395e-01 | 0.184 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 6.544395e-01 | 0.184 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.544395e-01 | 0.184 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.544395e-01 | 0.184 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.544395e-01 | 0.184 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.547078e-01 | 0.184 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.547078e-01 | 0.184 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 6.547078e-01 | 0.184 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.566403e-01 | 0.183 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 6.566403e-01 | 0.183 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.566403e-01 | 0.183 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.566403e-01 | 0.183 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.566403e-01 | 0.183 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.619863e-01 | 0.179 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.645483e-01 | 0.177 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.645483e-01 | 0.177 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.645483e-01 | 0.177 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.649702e-01 | 0.177 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.680662e-01 | 0.175 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.706378e-01 | 0.174 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 6.706405e-01 | 0.174 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 6.734040e-01 | 0.172 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.734040e-01 | 0.172 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.734040e-01 | 0.172 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 6.734040e-01 | 0.172 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.734040e-01 | 0.172 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.734040e-01 | 0.172 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.750689e-01 | 0.171 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.750689e-01 | 0.171 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.750689e-01 | 0.171 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.750689e-01 | 0.171 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 6.803854e-01 | 0.167 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.862699e-01 | 0.164 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 6.862699e-01 | 0.164 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.862699e-01 | 0.164 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.862699e-01 | 0.164 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.862699e-01 | 0.164 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.862699e-01 | 0.164 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.862699e-01 | 0.164 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.862699e-01 | 0.164 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 6.862699e-01 | 0.164 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.862699e-01 | 0.164 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.862699e-01 | 0.164 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.862699e-01 | 0.164 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.927567e-01 | 0.159 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 6.927567e-01 | 0.159 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.948635e-01 | 0.158 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.948635e-01 | 0.158 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.948635e-01 | 0.158 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 6.956916e-01 | 0.158 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.956916e-01 | 0.158 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.005194e-01 | 0.155 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.075451e-01 | 0.150 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.097079e-01 | 0.149 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.151426e-01 | 0.146 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.151426e-01 | 0.146 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.151426e-01 | 0.146 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.151426e-01 | 0.146 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 7.151426e-01 | 0.146 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.151426e-01 | 0.146 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.151426e-01 | 0.146 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.151701e-01 | 0.146 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.151701e-01 | 0.146 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.151701e-01 | 0.146 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.151701e-01 | 0.146 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.151701e-01 | 0.146 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.151701e-01 | 0.146 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 7.151701e-01 | 0.146 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.151701e-01 | 0.146 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.151701e-01 | 0.146 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.151701e-01 | 0.146 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.231005e-01 | 0.141 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.240304e-01 | 0.140 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.259300e-01 | 0.139 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.259300e-01 | 0.139 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.259300e-01 | 0.139 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 7.265155e-01 | 0.139 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.278207e-01 | 0.138 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 7.307077e-01 | 0.136 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.342767e-01 | 0.134 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 7.342767e-01 | 0.134 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.379584e-01 | 0.132 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.383183e-01 | 0.132 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.384236e-01 | 0.132 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.384236e-01 | 0.132 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.388880e-01 | 0.131 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.414096e-01 | 0.130 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.414096e-01 | 0.130 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.414096e-01 | 0.130 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.414096e-01 | 0.130 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.414096e-01 | 0.130 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.414096e-01 | 0.130 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.414096e-01 | 0.130 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 7.414096e-01 | 0.130 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.414096e-01 | 0.130 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.414096e-01 | 0.130 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.414096e-01 | 0.130 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.414096e-01 | 0.130 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.414096e-01 | 0.130 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.414096e-01 | 0.130 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.414096e-01 | 0.130 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.414334e-01 | 0.130 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.414334e-01 | 0.130 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.414334e-01 | 0.130 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.414334e-01 | 0.130 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 7.520930e-01 | 0.124 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.523046e-01 | 0.124 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.523046e-01 | 0.124 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.523046e-01 | 0.124 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.523046e-01 | 0.124 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.523046e-01 | 0.124 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.562307e-01 | 0.121 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.562307e-01 | 0.121 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.562307e-01 | 0.121 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.562307e-01 | 0.121 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.562307e-01 | 0.121 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.562307e-01 | 0.121 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.572642e-01 | 0.121 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 7.623903e-01 | 0.118 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.641946e-01 | 0.117 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.652333e-01 | 0.116 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.652333e-01 | 0.116 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.652333e-01 | 0.116 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.652333e-01 | 0.116 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.652333e-01 | 0.116 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.652333e-01 | 0.116 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.652333e-01 | 0.116 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 7.652333e-01 | 0.116 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.652333e-01 | 0.116 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.667883e-01 | 0.115 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.692677e-01 | 0.114 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.692677e-01 | 0.114 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.692677e-01 | 0.114 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.692677e-01 | 0.114 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.692677e-01 | 0.114 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.735265e-01 | 0.112 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.764518e-01 | 0.110 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.770566e-01 | 0.110 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.837683e-01 | 0.106 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.837683e-01 | 0.106 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.842588e-01 | 0.106 | 1 | 1 |
| Metabolism of polyamines | R-HSA-351202 | 7.842588e-01 | 0.106 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 7.852091e-01 | 0.105 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.852091e-01 | 0.105 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.852091e-01 | 0.105 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.852091e-01 | 0.105 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.868634e-01 | 0.104 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 7.868634e-01 | 0.104 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.868634e-01 | 0.104 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.868634e-01 | 0.104 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 7.868634e-01 | 0.104 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.868634e-01 | 0.104 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 7.868634e-01 | 0.104 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.868634e-01 | 0.104 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.868634e-01 | 0.104 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.868634e-01 | 0.104 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.868634e-01 | 0.104 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.868634e-01 | 0.104 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.868634e-01 | 0.104 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.868634e-01 | 0.104 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.881140e-01 | 0.103 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.887463e-01 | 0.103 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.945926e-01 | 0.100 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.001730e-01 | 0.097 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.065017e-01 | 0.093 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.065017e-01 | 0.093 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.065017e-01 | 0.093 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.065017e-01 | 0.093 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.065017e-01 | 0.093 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.065017e-01 | 0.093 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.065017e-01 | 0.093 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.065017e-01 | 0.093 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.078341e-01 | 0.093 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.093973e-01 | 0.092 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.099737e-01 | 0.092 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.099737e-01 | 0.092 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.108403e-01 | 0.091 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.108403e-01 | 0.091 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.142043e-01 | 0.089 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.142043e-01 | 0.089 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.142043e-01 | 0.089 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 8.142043e-01 | 0.089 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.175569e-01 | 0.087 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.178955e-01 | 0.087 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 8.202012e-01 | 0.086 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 8.202012e-01 | 0.086 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.232689e-01 | 0.084 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 8.232689e-01 | 0.084 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.232689e-01 | 0.084 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.243317e-01 | 0.084 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.243317e-01 | 0.084 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.243317e-01 | 0.084 | 0 | 0 |
| N-glycan trimming and elongation in the cis-Golgi | R-HSA-964739 | 8.243317e-01 | 0.084 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.243317e-01 | 0.084 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.243317e-01 | 0.084 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.243317e-01 | 0.084 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.243317e-01 | 0.084 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.243317e-01 | 0.084 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.243317e-01 | 0.084 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.243317e-01 | 0.084 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.243317e-01 | 0.084 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.243317e-01 | 0.084 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.243317e-01 | 0.084 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 8.243670e-01 | 0.084 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.273476e-01 | 0.082 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.273476e-01 | 0.082 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.273476e-01 | 0.082 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.273476e-01 | 0.082 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.273476e-01 | 0.082 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.273476e-01 | 0.082 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.299554e-01 | 0.081 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.311250e-01 | 0.080 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.311250e-01 | 0.080 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 8.311250e-01 | 0.080 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 8.320775e-01 | 0.080 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.322935e-01 | 0.080 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.396474e-01 | 0.076 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.396474e-01 | 0.076 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.396474e-01 | 0.076 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.396474e-01 | 0.076 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 8.405196e-01 | 0.075 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.405196e-01 | 0.075 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.405196e-01 | 0.075 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.405196e-01 | 0.075 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.405196e-01 | 0.075 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.405196e-01 | 0.075 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.405196e-01 | 0.075 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.405196e-01 | 0.075 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.405196e-01 | 0.075 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.405196e-01 | 0.075 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.405196e-01 | 0.075 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.405196e-01 | 0.075 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.405196e-01 | 0.075 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.409203e-01 | 0.075 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.414735e-01 | 0.075 | 0 | 0 |
| Disease | R-HSA-1643685 | 8.420246e-01 | 0.075 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.453985e-01 | 0.073 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.495343e-01 | 0.071 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.509577e-01 | 0.070 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 8.511475e-01 | 0.070 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.511475e-01 | 0.070 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 8.511475e-01 | 0.070 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.512682e-01 | 0.070 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 8.552168e-01 | 0.068 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.552168e-01 | 0.068 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.552168e-01 | 0.068 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.552168e-01 | 0.068 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.552168e-01 | 0.068 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.552168e-01 | 0.068 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.552168e-01 | 0.068 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.552168e-01 | 0.068 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 8.563703e-01 | 0.067 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.605309e-01 | 0.065 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.618909e-01 | 0.065 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.618909e-01 | 0.065 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.646829e-01 | 0.063 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.646829e-01 | 0.063 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.646829e-01 | 0.063 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.685602e-01 | 0.061 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.685602e-01 | 0.061 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.685602e-01 | 0.061 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.685602e-01 | 0.061 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.685602e-01 | 0.061 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.685602e-01 | 0.061 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 8.685602e-01 | 0.061 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.685602e-01 | 0.061 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.685602e-01 | 0.061 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.692832e-01 | 0.061 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.713506e-01 | 0.060 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.719193e-01 | 0.060 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.719193e-01 | 0.060 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.719193e-01 | 0.060 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.719193e-01 | 0.060 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.719193e-01 | 0.060 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.719303e-01 | 0.060 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.723515e-01 | 0.059 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.759477e-01 | 0.058 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.759766e-01 | 0.058 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.775468e-01 | 0.057 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.792130e-01 | 0.056 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.796421e-01 | 0.056 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.796421e-01 | 0.056 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.806746e-01 | 0.055 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 8.806746e-01 | 0.055 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 8.806746e-01 | 0.055 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.806746e-01 | 0.055 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.806746e-01 | 0.055 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.812731e-01 | 0.055 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 8.814212e-01 | 0.055 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.853430e-01 | 0.053 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 8.865684e-01 | 0.052 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 8.899915e-01 | 0.051 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.899915e-01 | 0.051 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.899915e-01 | 0.051 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.899915e-01 | 0.051 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 8.902653e-01 | 0.050 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 8.902653e-01 | 0.050 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 8.903082e-01 | 0.050 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 8.903082e-01 | 0.050 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 8.903082e-01 | 0.050 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 8.916732e-01 | 0.050 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.916732e-01 | 0.050 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.916732e-01 | 0.050 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 8.916732e-01 | 0.050 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.916732e-01 | 0.050 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.916732e-01 | 0.050 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 8.926928e-01 | 0.049 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.926928e-01 | 0.049 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.926928e-01 | 0.049 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.938282e-01 | 0.049 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 8.961950e-01 | 0.048 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 8.993830e-01 | 0.046 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.013518e-01 | 0.045 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.013518e-01 | 0.045 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.016585e-01 | 0.045 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 9.016585e-01 | 0.045 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.016585e-01 | 0.045 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.016585e-01 | 0.045 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.016585e-01 | 0.045 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.016585e-01 | 0.045 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.016585e-01 | 0.045 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.052982e-01 | 0.043 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.056712e-01 | 0.043 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.056712e-01 | 0.043 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.061357e-01 | 0.043 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.107240e-01 | 0.041 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.107240e-01 | 0.041 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.107240e-01 | 0.041 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 9.107240e-01 | 0.041 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 9.107240e-01 | 0.041 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.107240e-01 | 0.041 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.107240e-01 | 0.041 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.107240e-01 | 0.041 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.107240e-01 | 0.041 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.107240e-01 | 0.041 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.107240e-01 | 0.041 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.109032e-01 | 0.041 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.127030e-01 | 0.040 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.137755e-01 | 0.039 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.189542e-01 | 0.037 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 9.189542e-01 | 0.037 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.189542e-01 | 0.037 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.189542e-01 | 0.037 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.189542e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.189542e-01 | 0.037 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.189542e-01 | 0.037 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.189542e-01 | 0.037 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.192406e-01 | 0.037 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.192406e-01 | 0.037 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.192406e-01 | 0.037 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.222165e-01 | 0.035 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.253153e-01 | 0.034 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.264262e-01 | 0.033 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.264262e-01 | 0.033 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.264262e-01 | 0.033 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.264262e-01 | 0.033 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.264262e-01 | 0.033 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.264262e-01 | 0.033 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.264262e-01 | 0.033 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.264262e-01 | 0.033 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.264262e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.276369e-01 | 0.033 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.285178e-01 | 0.032 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.294298e-01 | 0.032 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.309568e-01 | 0.031 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.331312e-01 | 0.030 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.332097e-01 | 0.030 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.332097e-01 | 0.030 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.332097e-01 | 0.030 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.332097e-01 | 0.030 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 9.332097e-01 | 0.030 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.332097e-01 | 0.030 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.332097e-01 | 0.030 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.332097e-01 | 0.030 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.332097e-01 | 0.030 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.332097e-01 | 0.030 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.351211e-01 | 0.029 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.351211e-01 | 0.029 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.361934e-01 | 0.029 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.379426e-01 | 0.028 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.379426e-01 | 0.028 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.393681e-01 | 0.027 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.393681e-01 | 0.027 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.393681e-01 | 0.027 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.393681e-01 | 0.027 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.393681e-01 | 0.027 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.393681e-01 | 0.027 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.402929e-01 | 0.027 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.410517e-01 | 0.026 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.410517e-01 | 0.026 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.414167e-01 | 0.026 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.418457e-01 | 0.026 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.425110e-01 | 0.026 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.431812e-01 | 0.025 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.449590e-01 | 0.025 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.449590e-01 | 0.025 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.449590e-01 | 0.025 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.449590e-01 | 0.025 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.450611e-01 | 0.025 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.450611e-01 | 0.025 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.455570e-01 | 0.024 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.455570e-01 | 0.024 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.459339e-01 | 0.024 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.460791e-01 | 0.024 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.494031e-01 | 0.023 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.497330e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.497330e-01 | 0.022 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.497330e-01 | 0.022 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.500347e-01 | 0.022 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.500347e-01 | 0.022 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.500347e-01 | 0.022 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.500347e-01 | 0.022 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.500347e-01 | 0.022 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.500347e-01 | 0.022 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.500347e-01 | 0.022 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.500347e-01 | 0.022 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.500347e-01 | 0.022 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.500347e-01 | 0.022 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.500347e-01 | 0.022 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.509068e-01 | 0.022 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.516549e-01 | 0.022 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.527682e-01 | 0.021 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.536022e-01 | 0.021 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.536022e-01 | 0.021 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.540044e-01 | 0.020 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.546426e-01 | 0.020 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.546426e-01 | 0.020 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.546426e-01 | 0.020 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.546426e-01 | 0.020 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.546426e-01 | 0.020 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.546426e-01 | 0.020 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.560397e-01 | 0.020 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.562999e-01 | 0.019 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.562999e-01 | 0.019 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.565040e-01 | 0.019 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.571856e-01 | 0.019 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.571856e-01 | 0.019 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.571856e-01 | 0.019 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.580970e-01 | 0.019 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.588258e-01 | 0.018 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.588258e-01 | 0.018 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.588258e-01 | 0.018 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.588258e-01 | 0.018 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.588258e-01 | 0.018 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.588258e-01 | 0.018 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.593198e-01 | 0.018 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.605029e-01 | 0.018 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.609457e-01 | 0.017 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.621429e-01 | 0.017 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.621429e-01 | 0.017 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.626234e-01 | 0.017 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.626234e-01 | 0.017 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.626234e-01 | 0.017 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.626234e-01 | 0.017 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.626234e-01 | 0.017 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 9.626234e-01 | 0.017 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.626234e-01 | 0.017 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.631107e-01 | 0.016 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.635489e-01 | 0.016 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.635489e-01 | 0.016 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.635728e-01 | 0.016 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.647810e-01 | 0.016 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.647810e-01 | 0.016 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.660709e-01 | 0.015 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.660709e-01 | 0.015 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.660709e-01 | 0.015 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.660709e-01 | 0.015 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.664126e-01 | 0.015 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.664126e-01 | 0.015 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.664126e-01 | 0.015 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.680905e-01 | 0.014 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.682614e-01 | 0.014 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.689628e-01 | 0.014 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.690388e-01 | 0.014 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.692007e-01 | 0.014 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.692007e-01 | 0.014 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.692007e-01 | 0.014 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.699400e-01 | 0.013 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.702507e-01 | 0.013 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.714664e-01 | 0.013 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.719068e-01 | 0.012 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.720419e-01 | 0.012 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.720419e-01 | 0.012 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.737098e-01 | 0.012 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.737098e-01 | 0.012 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.738376e-01 | 0.012 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.741259e-01 | 0.011 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.746211e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.755641e-01 | 0.011 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.756310e-01 | 0.011 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.757824e-01 | 0.011 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.769626e-01 | 0.010 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.773057e-01 | 0.010 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.776964e-01 | 0.010 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.790394e-01 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.790882e-01 | 0.009 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.790882e-01 | 0.009 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.790882e-01 | 0.009 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.795642e-01 | 0.009 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.795642e-01 | 0.009 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.795642e-01 | 0.009 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.808764e-01 | 0.008 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.810177e-01 | 0.008 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.810177e-01 | 0.008 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.810177e-01 | 0.008 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.810947e-01 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.814757e-01 | 0.008 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.814757e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.815162e-01 | 0.008 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.815162e-01 | 0.008 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.819445e-01 | 0.008 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.827693e-01 | 0.008 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.827693e-01 | 0.008 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.827693e-01 | 0.008 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.827693e-01 | 0.008 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.827693e-01 | 0.008 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.829428e-01 | 0.007 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.843594e-01 | 0.007 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.843594e-01 | 0.007 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.843594e-01 | 0.007 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.843793e-01 | 0.007 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.843793e-01 | 0.007 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.855143e-01 | 0.006 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.855143e-01 | 0.006 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.858028e-01 | 0.006 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.858028e-01 | 0.006 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.858028e-01 | 0.006 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.858028e-01 | 0.006 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.865700e-01 | 0.006 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.868060e-01 | 0.006 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.870546e-01 | 0.006 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.871131e-01 | 0.006 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.871131e-01 | 0.006 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.871131e-01 | 0.006 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.876562e-01 | 0.005 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.878154e-01 | 0.005 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.879531e-01 | 0.005 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.883026e-01 | 0.005 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.883026e-01 | 0.005 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.883638e-01 | 0.005 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.883638e-01 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.886467e-01 | 0.005 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.893117e-01 | 0.005 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.893117e-01 | 0.005 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.893823e-01 | 0.005 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.893823e-01 | 0.005 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.894237e-01 | 0.005 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.894642e-01 | 0.005 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.894642e-01 | 0.005 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.903791e-01 | 0.004 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.903791e-01 | 0.004 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.909945e-01 | 0.004 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.912521e-01 | 0.004 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.912521e-01 | 0.004 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.913285e-01 | 0.004 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.920597e-01 | 0.003 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.924853e-01 | 0.003 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.927928e-01 | 0.003 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.928916e-01 | 0.003 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.934582e-01 | 0.003 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.936006e-01 | 0.003 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.940623e-01 | 0.003 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.950612e-01 | 0.002 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.951083e-01 | 0.002 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.954683e-01 | 0.002 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.954938e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.955601e-01 | 0.002 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.958640e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.959701e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.961088e-01 | 0.002 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.961088e-01 | 0.002 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.962043e-01 | 0.002 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.963423e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.966802e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.979856e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.981443e-01 | 0.001 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.982568e-01 | 0.001 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.984714e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.986127e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.987409e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.989629e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.989675e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.990588e-01 | 0.000 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.992248e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.992964e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.992964e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.992964e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.993378e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.993615e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.993788e-01 | 0.000 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.994741e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.995228e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.995228e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.995228e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.995552e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.995719e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.996403e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.996763e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.997129e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.997278e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.997581e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.997805e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.997805e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.997961e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.997961e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.998192e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.998873e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999095e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999285e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999378e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999379e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999653e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999685e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999685e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999708e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999741e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999756e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999817e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999827e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999838e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999841e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999869e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999871e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999875e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999902e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999915e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999919e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999931e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999932e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999940e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999944e-01 | 0.000 | 1 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999963e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999973e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999980e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999985e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999986e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999986e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999994e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999995e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999997e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999999e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |